典型肉鸡生产链中弯曲菌耐药性调查及风险评估研究
|
摘要
弯曲菌是一类重要的食源性肠道病原菌,世界范围内每年弯曲菌感染病例数约4-5亿。随着抗菌药物在食品动物养殖中的大量使用,弯曲菌的耐药现状越来越严重。调查研究表明,加工和消费受到弯曲菌污染的鸡肉是人类弯曲菌感染的主要途径之一。在我国,对于弯曲菌流行和耐药性的监测还不完善,肉鸡中弯曲菌的流行和耐药性的报道也相对较少。本研究旨在了解弯曲菌在我国肉鸡生产链中的污染、传播及其抗菌药物耐药性情况,进而在已有数据的基础之上开展肉鸡源弯曲菌耐药性风险评估研究。
在2012至2013年,本研究从上海和青岛的两个典型肉鸡生产链中分别采集了肉鸡盲肠样本142和118份,屠宰胴体样本135和110份,以及市售鸡肉样本128和128份,在青岛肉鸡生产链中还采集了分割鸡肉样品104份,各分离得到弯曲菌259(空肠弯曲菌：106；结肠弯曲菌：153)株和282(空肠弯曲菌：142；结肠弯曲菌：140)株。值得注意的是,肉鸡中结肠弯曲菌的分离率已经达到甚至超过了空肠弯曲菌。药敏结果显示,分离自上海和青岛肉鸡生产链的541株弯曲菌均至少耐1种抗菌药物。两地区所分离的弯曲菌对环丙沙星耐药率最高(>99.0%)；其次是对四环素的耐药率(86.0%)。另外,克林霉素、庆大霉素和红霉素的耐药率也比较高,均在62%以上；上海和青岛弯曲菌的氟苯尼考耐药率分别为20.1%和4.6%。结肠弯曲菌对四环素、克林霉素、庆大霉素和红霉素的耐药率明显高于空肠弯曲菌,氟苯尼考耐药率则相反。多重耐药情况非常严重,两地弯曲菌的多重耐药率分别达到了87.9%和73.4%,远高于其它国家等。分子分型结果显示,不同来源的弯曲菌可能具有相同PFGE谱型,这说明弯曲菌可以随着肉鸡生产链传播。
基于OIE风险分析框架和FDA152号抗菌药物耐药性风险评估指南,本研究结合我国细菌耐药风险评估的现状建立了肉鸡源细菌耐药性定性风险评估模型。该模型包括：危害特征描述、释放评估、暴露评估、后果评估和风险估计五个部分,在评估过程中使用“矩阵法”和“非矩阵法”两种方法对风险参数进行整合。之后,运用所建立的评估模型对我国肉鸡源耐氟喹诺酮类药物(FQs)弯曲菌进行了评估。结果表明,我国肉鸡源耐FQs弯曲菌的释放风险“极高”；消费者因消费鸡肉而暴露于耐FQs弯曲菌的风险“较高”；弯曲菌的FQs耐药性对弯曲菌病治疗造成的影响“非常严重”。利用“矩阵法”综合上述结果得到如下结论：在我国肉鸡养殖中使用FQs所导致的耐FQs弯曲菌对我国消费者的健康构成了“高水平”的风险。
本研究基于OIE风险分析框架和FDA风险评估指南,并结合我国目前开展动物源细菌耐药性风险评估所具备的基本条件建立了一个“农场-餐桌”的肉鸡源细菌耐药性随机定量风险评估模型。该模型利用统计分析软件(如@riskTM等)进行蒙特卡罗模拟获得一个包含95%置信区间的风险评估结果平均值,然后通过敏感性分析确定各模型参数对风险评估结果不确定度的影响大小。最后,运用所建立的模型评估了我国肉鸡源耐FQs弯曲菌对我国消费者健康的影响。评估结果表明,我国2010年和2011年受到肉鸡源耐FQs弯曲菌感染影响的病例数分别为：N2010=0.2630×106(95%CI:0.038-0.728)和N2011=0.2637×106(95%CI:0.039-0.728)敏感性分析结果表明,服用FQs治疗耐FQs弯曲菌感染的概率(PFQ)对模型结果Nm的不确定度的影响最大,其次为PF和PA,而参数PT的影响最小。
综上所述,我国肉鸡源弯曲菌的耐药情况非常严重,多重耐药的比例远高于其它国家。结肠弯曲菌正逐渐替代空肠弯曲菌成为肉鸡中的优势弯曲菌群,且其对四环素、克林霉素、庆大霉素和红霉素的耐药率显著地高于空肠弯曲菌。PFGE分型结果表明,肉鸡源弯曲菌可以随着肉鸡的生产链传播。风险评估结果显示,我国消费者受到肉鸡源耐FQs弯曲菌影响的风险较高。总之,我国肉鸡源弯曲菌耐药性的严峻形势,以及耐药弯曲菌随着肉鸡生产链传播给消费者并对其健康造成影响的事实理应受到更多的关注。
Campylobacter spp. are the most frequently identified foodborne bacteria causing gastroenteritis throughout the world. Campylobacter cause approximately400to500million human infection cases worldwide each year. Along with the antimicrobial use in food-producing animal, Campylobacter are increasingly resistant to some important antibiotics, which compromises clinical therapy and presents a major threat to public health. Epidemiological studies have demonstrated that handling and consumption of contaminated broiler meat, is a major source of human Campylobacter infections. In China, an active surveillance system to monitor the prevalence and antimicrobial resistance of Campylobacter from farm to retail is not yet available, and little information has been reported on Campylobacter in broiler. The prevalence and distribution of Campylobacter along the broiler production chain is unknown in China, which hampers the implementation of interventions. This study was to investigate the prevalence and antimicrobial resistance of Campylobacter in broiler production chain, under which two antimicrobial resistance risk assessment models on Campylobacter in broiler were developed.
During2012-2013,142&118broiler ceca,135&110broiler carcasses, and128&128broiler meat samples were randomly collected from broiler farm, slaughterhouse and supermarket of the boiler production chains in Shanghai&Qingdao, respectively. Additional104boiler meat product samples were collected from slaughterhouse in Qingdao. A total of259(C.jejuni:106; C. coli:153) and282(C. jejuni:142; C. coli:140) Campylobacter were isolated from Shanghai and Qingdao, respectively. It worth noting that C. coli is becoming the predominant species in broiler in China. All541Campylobacter isolates were resistant to at least one of the tested antimicrobial agents. Notably, nearly100%of the isolates were resistant to ciprofloxacin. Tetracycline resistance of Campylobacter was also very severe. Besides, the resistance rates of these isolates to clindamycin, gentamicin, and erythromycin all exceeded62%. The lowest resistance observed in these Campylobacter isolates was to florfenicol, and florfenicol resistance rate of Campylobacter isolated from Shanghai and Qingdao were20.1%and4.6%, respectively. Contrary to florfenicol resistance, the resistance rates of C.coli to tetracycline, clindamycin, gentamicin, and erythromycin were higher than that of C. jejuni. The rate of MDR for Campylobacter from Shanghai and Qingdao were respectively87.9%and73.4%, which were much higher than that reported in other countries. Furthermore, isolates from different production stages might have the same PFGE patterns, indicating their transmission along the broiler production chain.
Referring to risk analysis framework recommended by OIE and FDA Guidance Document152, we developed a qualitative risk assessment model on antimicrobial resistance from food-producing animals. The model contains five parts:hazard characterization, release assessment, exposure assessment, consequence assessment and risk eatimate. Throughout the model, both "metrix method" and "non-metrix method" were used to combined the qualitative probabilities/parameters. Then, the qualitative model was used to evaluate the risk from FQs-resistant Campylobacter attributed to the use of FQs in the broiler rearing. The results revealed that the risk of developing FQs resistance, contributed to the use of FQs in broiler production, for Campylobacter was extremely high; the probability of consumer exposure to FQs-resistant Campylobacter in broiler meat was "high", and the influence of FQs-resistant Campylobacter cases attributable to chicken and affected by the FQs resistance was "highly mmportant" in China.
Based on risk analysis framework recommended by OIE and the anmicrobial resistance risk assessmenr theory of FDA, we established a "farm-consumption"quantitative risk assessment model on antimicrobial resistance in food-producing animals. The software program@riskTM was used to simulate the risk assessment model. A total of10,000simulations were run and medians and the output distributions (95%CI) were reported. By sensitivity analysis, we can lern about the uncertainty in the value foroutput contributed to each input of the assessment model. The quantitative model was used to evaluate the risk from FQs-resistant Campylobacter attributed to the use of FQs in the broiler production. The results of the risk assessment revealed that the theoretical numbers of FQs-resistant Campylobacter cases attributable to chicken and affected by the FQs resistance in2010and2011were0.2630×106and0.2637×106, respectively, and the probability of taking FQs for Campylobacter-associated diarrhea (PFQ) contributed the most toward uncertainty of quantitative risk assessment model.
In summary, the antimicrobial resistance level of Campylobacter in China was very high, and higher than that in other countries. The resistance of C.coli to tetracycline, clindamycin, gentamicin, and erythromycin were severer than that of C. jejuni, and C. coli is becoming the predominant Campylobacter species in chickens in China. The PFGE results indicated the transmission of Campylobacter along the broiler production chain. Antimicrobial resistance risk assessment showed that human health risks due to FQs-selected resistance of Campylobacter in broiler were high. Taken together, the hazard for Campylobacter resistance in broiler deserves further investigation.
在2012至2013年,本研究从上海和青岛的两个典型肉鸡生产链中分别采集了肉鸡盲肠样本142和118份,屠宰胴体样本135和110份,以及市售鸡肉样本128和128份,在青岛肉鸡生产链中还采集了分割鸡肉样品104份,各分离得到弯曲菌259(空肠弯曲菌：106；结肠弯曲菌：153)株和282(空肠弯曲菌：142；结肠弯曲菌：140)株。值得注意的是,肉鸡中结肠弯曲菌的分离率已经达到甚至超过了空肠弯曲菌。药敏结果显示,分离自上海和青岛肉鸡生产链的541株弯曲菌均至少耐1种抗菌药物。两地区所分离的弯曲菌对环丙沙星耐药率最高(>99.0%)；其次是对四环素的耐药率(86.0%)。另外,克林霉素、庆大霉素和红霉素的耐药率也比较高,均在62%以上；上海和青岛弯曲菌的氟苯尼考耐药率分别为20.1%和4.6%。结肠弯曲菌对四环素、克林霉素、庆大霉素和红霉素的耐药率明显高于空肠弯曲菌,氟苯尼考耐药率则相反。多重耐药情况非常严重,两地弯曲菌的多重耐药率分别达到了87.9%和73.4%,远高于其它国家等。分子分型结果显示,不同来源的弯曲菌可能具有相同PFGE谱型,这说明弯曲菌可以随着肉鸡生产链传播。
基于OIE风险分析框架和FDA152号抗菌药物耐药性风险评估指南,本研究结合我国细菌耐药风险评估的现状建立了肉鸡源细菌耐药性定性风险评估模型。该模型包括：危害特征描述、释放评估、暴露评估、后果评估和风险估计五个部分,在评估过程中使用“矩阵法”和“非矩阵法”两种方法对风险参数进行整合。之后,运用所建立的评估模型对我国肉鸡源耐氟喹诺酮类药物(FQs)弯曲菌进行了评估。结果表明,我国肉鸡源耐FQs弯曲菌的释放风险“极高”；消费者因消费鸡肉而暴露于耐FQs弯曲菌的风险“较高”；弯曲菌的FQs耐药性对弯曲菌病治疗造成的影响“非常严重”。利用“矩阵法”综合上述结果得到如下结论：在我国肉鸡养殖中使用FQs所导致的耐FQs弯曲菌对我国消费者的健康构成了“高水平”的风险。
本研究基于OIE风险分析框架和FDA风险评估指南,并结合我国目前开展动物源细菌耐药性风险评估所具备的基本条件建立了一个“农场-餐桌”的肉鸡源细菌耐药性随机定量风险评估模型。该模型利用统计分析软件(如@riskTM等)进行蒙特卡罗模拟获得一个包含95%置信区间的风险评估结果平均值,然后通过敏感性分析确定各模型参数对风险评估结果不确定度的影响大小。最后,运用所建立的模型评估了我国肉鸡源耐FQs弯曲菌对我国消费者健康的影响。评估结果表明,我国2010年和2011年受到肉鸡源耐FQs弯曲菌感染影响的病例数分别为：N2010=0.2630×106(95%CI:0.038-0.728)和N2011=0.2637×106(95%CI:0.039-0.728)敏感性分析结果表明,服用FQs治疗耐FQs弯曲菌感染的概率(PFQ)对模型结果Nm的不确定度的影响最大,其次为PF和PA,而参数PT的影响最小。
综上所述,我国肉鸡源弯曲菌的耐药情况非常严重,多重耐药的比例远高于其它国家。结肠弯曲菌正逐渐替代空肠弯曲菌成为肉鸡中的优势弯曲菌群,且其对四环素、克林霉素、庆大霉素和红霉素的耐药率显著地高于空肠弯曲菌。PFGE分型结果表明,肉鸡源弯曲菌可以随着肉鸡的生产链传播。风险评估结果显示,我国消费者受到肉鸡源耐FQs弯曲菌影响的风险较高。总之,我国肉鸡源弯曲菌耐药性的严峻形势,以及耐药弯曲菌随着肉鸡生产链传播给消费者并对其健康造成影响的事实理应受到更多的关注。
Campylobacter spp. are the most frequently identified foodborne bacteria causing gastroenteritis throughout the world. Campylobacter cause approximately400to500million human infection cases worldwide each year. Along with the antimicrobial use in food-producing animal, Campylobacter are increasingly resistant to some important antibiotics, which compromises clinical therapy and presents a major threat to public health. Epidemiological studies have demonstrated that handling and consumption of contaminated broiler meat, is a major source of human Campylobacter infections. In China, an active surveillance system to monitor the prevalence and antimicrobial resistance of Campylobacter from farm to retail is not yet available, and little information has been reported on Campylobacter in broiler. The prevalence and distribution of Campylobacter along the broiler production chain is unknown in China, which hampers the implementation of interventions. This study was to investigate the prevalence and antimicrobial resistance of Campylobacter in broiler production chain, under which two antimicrobial resistance risk assessment models on Campylobacter in broiler were developed.
During2012-2013,142&118broiler ceca,135&110broiler carcasses, and128&128broiler meat samples were randomly collected from broiler farm, slaughterhouse and supermarket of the boiler production chains in Shanghai&Qingdao, respectively. Additional104boiler meat product samples were collected from slaughterhouse in Qingdao. A total of259(C.jejuni:106; C. coli:153) and282(C. jejuni:142; C. coli:140) Campylobacter were isolated from Shanghai and Qingdao, respectively. It worth noting that C. coli is becoming the predominant species in broiler in China. All541Campylobacter isolates were resistant to at least one of the tested antimicrobial agents. Notably, nearly100%of the isolates were resistant to ciprofloxacin. Tetracycline resistance of Campylobacter was also very severe. Besides, the resistance rates of these isolates to clindamycin, gentamicin, and erythromycin all exceeded62%. The lowest resistance observed in these Campylobacter isolates was to florfenicol, and florfenicol resistance rate of Campylobacter isolated from Shanghai and Qingdao were20.1%and4.6%, respectively. Contrary to florfenicol resistance, the resistance rates of C.coli to tetracycline, clindamycin, gentamicin, and erythromycin were higher than that of C. jejuni. The rate of MDR for Campylobacter from Shanghai and Qingdao were respectively87.9%and73.4%, which were much higher than that reported in other countries. Furthermore, isolates from different production stages might have the same PFGE patterns, indicating their transmission along the broiler production chain.
Referring to risk analysis framework recommended by OIE and FDA Guidance Document152, we developed a qualitative risk assessment model on antimicrobial resistance from food-producing animals. The model contains five parts:hazard characterization, release assessment, exposure assessment, consequence assessment and risk eatimate. Throughout the model, both "metrix method" and "non-metrix method" were used to combined the qualitative probabilities/parameters. Then, the qualitative model was used to evaluate the risk from FQs-resistant Campylobacter attributed to the use of FQs in the broiler rearing. The results revealed that the risk of developing FQs resistance, contributed to the use of FQs in broiler production, for Campylobacter was extremely high; the probability of consumer exposure to FQs-resistant Campylobacter in broiler meat was "high", and the influence of FQs-resistant Campylobacter cases attributable to chicken and affected by the FQs resistance was "highly mmportant" in China.
Based on risk analysis framework recommended by OIE and the anmicrobial resistance risk assessmenr theory of FDA, we established a "farm-consumption"quantitative risk assessment model on antimicrobial resistance in food-producing animals. The software program@riskTM was used to simulate the risk assessment model. A total of10,000simulations were run and medians and the output distributions (95%CI) were reported. By sensitivity analysis, we can lern about the uncertainty in the value foroutput contributed to each input of the assessment model. The quantitative model was used to evaluate the risk from FQs-resistant Campylobacter attributed to the use of FQs in the broiler production. The results of the risk assessment revealed that the theoretical numbers of FQs-resistant Campylobacter cases attributable to chicken and affected by the FQs resistance in2010and2011were0.2630×106and0.2637×106, respectively, and the probability of taking FQs for Campylobacter-associated diarrhea (PFQ) contributed the most toward uncertainty of quantitative risk assessment model.
In summary, the antimicrobial resistance level of Campylobacter in China was very high, and higher than that in other countries. The resistance of C.coli to tetracycline, clindamycin, gentamicin, and erythromycin were severer than that of C. jejuni, and C. coli is becoming the predominant Campylobacter species in chickens in China. The PFGE results indicated the transmission of Campylobacter along the broiler production chain. Antimicrobial resistance risk assessment showed that human health risks due to FQs-selected resistance of Campylobacter in broiler were high. Taken together, the hazard for Campylobacter resistance in broiler deserves further investigation.
引文
[1]R. Zhang, K. Eggleston, V. Rotimi, et al. Antibiotic Resistance as a Global Threat:Evidence from China, Kuwait and the United States. Global Health.2006,2 (6):1-14
[2]F.F. Barrett, R.F. McGehee Jr, M. Finland. Methicillin-Resistant Staphylococcus Aureus at Boston City Hospital:Bacteriologic and Epidemiologic Observations. New England Journal of Medicine.1968,279 (9):441-448
[3]R. Wise. Antimicrobial Resistance:Priorities for Action. Journal of Antimicrobial Chemotherapy.2002,49 (4):585-586
[4]J. Carlet, J.L. Mainardi. Antibacterial Agents:Back to the Future? Can We Live with Only Colistin, Co-Trimoxazole and Fosfomycin? Clinical Microbiology and Infection.2012,18 (1):1-3
[5]C. Gagliotti, A. Balode, F. Baquero, et al. Escherichia Coli and Staphylococcus Aureus:Bad News and Good News from the European Antimicrobial Resistance Surveillance Network (Ears-Net, Formerly Earss),2002 to 2009.2011
[6]T.R. Walsh, J. Weeks, D.M. Livermore, et al. Dissemination of Ndm-1 Positive Bacteria in the New Delhi Environment and Its Implications for Human Health:An Environmental Point Prevalence Study. The Lancet infectious diseases.2011,11 (5):355-362
[7]W. Couet, N. Gregoire, S. Marchand, et al. Colistin Pharmacokinetics:The Fog Is Lifting. Clinical Microbiology and Infection.2012,18 (1):30-39
[8]J. Carlet, V. Jarlier, S. Harbarth, et al. Ready for a World without Antibiotics? The Pensieres Antibiotic Resistance Call to Action. Antimicrobial resistance and infection control.2012,1 (1):1-13
[9]R. Wise, T. Hart, O. Cars, et al. Antimicrobial Resistance:Is a Major Threat to Public Health. BMJ:British Medical Journal.1998,317 (7159):609
[10]F. Bager, M. Madsen, J. Christensen, et al. Avoparcin Used as a Growth Promoter Is Associated with the Occurrence of Vancomycin-Resistant Enterococcus Faecium on Danish Poultry and Pig Farms. Preventive Veterinary Medicine.1997,31 (1-2):95-112
[11]F.M. Aarestrup, B. Carstensen. Effect of Tylosin Used as a Growth Promoter on the Occurrence of Macrolide-Resistant Enterococci and Staphylococci in Pigs. Microbial Drug Resistance. 1998,4 (4):307-312
[12]J. Acar, M. Casewell, J. Freeman, et al. Avoparcin and Virginiamycin as Animal Growth Promoters:A Plea for Science in Decision-Making. Clinical Microbiology and Infection.2000,6 (9): 477-482
[13]FDA. Enrofloxacin for Poultry; Final Decision on Withdrawal of New Animal Drug Application Following Formal Evidentiary Public Hearing; Availability. FR Doc.2005:05-15224
[14]H.S. Hurd, S. Doores, D. Hayes, et al. Public Health Consequences of Macrolide Use in Food Animals:A Deterministic Risk Assessment. Journal of Food Protection.2004,67(5):980-992
[15]L.A. Cox, D.A. Popken. Quantifying Human Health Risks from Virginiamycin Used in Chickens. Risk Analysis.2004,24 (1):271-288
[16]L.A.T. Cox Jr, D.A. Popken, J.J. Mathers. Human Health Risk Assessment of Penicillin/Aminopenicillin Resistance in Enterococci Due to Penicillin Use in Food Animals. Risk Analysis.2009,29 (6):796-805
[17]G.M. Ruiz-Palacios. The Health Burden of Campylobacter Infection and the Impact of Antimicrobial Resistance:Playing Chicken. Clinical Infectious Diseases.2007,44 (5):701-703
[18]E. EFSA. Panel on Biological Hazards (Biohaz). Scientific Opinion on Quantification of the Risk Posed by Broiler Meat to Human Campylobacteriosis in the Eu. EFSA Journal.2010,8:1437
[19]B.M. Allos. Campylobacter Jejuni Infections:Update on Emerging Issues and Trends. Clinical Infectious Diseases.2001,32 (8):1201-1206
[20]J. Engberg, F.M. Aarestrup, D.E. Taylor, et al. Quinolone and Macrolide Resistance in Campylobacter Jejuni and C. Coli:Resistance Mechanisms and Trends in Human Isolates. Emerging Infectious Diseases.2001,7 (1):24-34
[21]张心如,罗宜熟,杜干英等.动物源性耐药菌与人类安全.兽药与饲料添加剂.2004,9(3)：3-6
[22]C. Fitzgerald, I. Nachamkin, P. Murray, et al. Campylobacter and Arcobacter. Manual of clinical microbiology:Volume 1.2006 (Ed.9):933-946
[23]Y. Saenz, M. Zarazaga, M. Lantero, et al. Antibiotic Resistance in Campylobacter strains Isolated from Animals, Foods, and Humans in Spain in 1997-1998. Antimicrobial Agents and Chemotherapy.2000,44 (2):267-271
[24]A.O. Coker, R.D. Isokpehi, B.N. Thomas, et al. Human Campylobacteriosis in Developing Countries. Emerging Infectious Diseases.2002,8 (3):237-244
[25]M. Shahid, M. Amjad, S.U. Kazmi. Breast Feeding May Protect Children against Campylobacter Jejuni Associated Diarrhoea. Journal of the College of Physicians and Surgeons Pakistan.1996,6 (1):43-46
[26]M. Alam, Y.N. Akhtar, S.S. Ali, et al. Seasonal Variation in Bacterial Pathogens Isolated from Stool Samples in Karachi, Pakistan. Journal of Pakistan Medical Association.2003,53 (3):125-129
[27]J. Bardon, M. Kolaf, R. Karpiskova, et al. Prevalence of Thermotolerant Campylobacter Spp. In Broilers at Retail in the Czech Republic and Their Antibiotic Resistance. Food Control.2011,22 (2): 328-332
[28]M.J. Blaser, J. Engberg, I. Nachamkin, et al. Clinical Aspects of Campylobacter Jejuni and Campylobacter Coli Infections. ASM Press,2008
[29]A. Lastovica, M. Skirrow. Clinical significance of Campylobacter and related species other than C. jejuni and C. Coli. Campylobacter.2000,2:89-120
[30]D.J. Wilson, E. Gabriel, A.J. Leatherbarrow, et al. Tracing the Source of Campylobacteriosis. PLOS Genetics.2008,4 (9):e1000203
[31]J. Silva, D. Leite, M. Fernandes, et al. Campylobacter Spp. As a Foodborne Pathogen:A Review. Frontiers in microbiology.2011,2
[32]B.M. Allos, M.J. Blaser. Campylobacter Jejuni and the Expanding Spectrum of Related Infections. Clinical Infectious Diseases.1995,20 (5):1092-1099
[33]N. McCarthy, J. Giesecke. Incidence of Guillain-Barre Syndrome Following Infection with Campylobacter Jejuni. American Journal of Epidemiology.2001,153 (6):610-614
[34]H. Jiang, M.-J. Zhang, R.-C. Liu, et al. Characteristics of Lipo-Oligosaccharide Loci of Campylobacter Jejuni Isolates Associated with Guillain-Barre Syndrome from Hebei, China. International Journal of Molecular Sciences.2010,11 (3):1155-1161
[35]M. Zhang, Q. Li, L. He, et al. Association Study between an Outbreak of Guillain-Barre Syndrome in Jilin, China, and Preceding Campylobacter Jejuni Infection. Foodborne Pathogens and Disease.2010,7 (8):913-919
[36]J.L. Huang, H.Y. Xu, G.Y. Bao, et al. Epidemiological Surveillance of Campylobacter Jejuni in Chicken, Dairy Cattle and Diarrhoea Patients. Emerging Infectious Diseases.2009,137 (8): 1111-1120
[37]D.J. Kelly. The Physiology and Metabolism of Campylobacter Jejuni and Helicobacter Pylori. Symposium series (Society for Applied Microbiology).2001 (30):16S-24S
[38]N.J. Stern, M.R. Clavero, J.S. Bailey, et al. Campylobacter Spp. In Broilers on the Farm and after Transport. Poultry Science.1995,74 (6):937-941
[39]N. Diane G. The Ecology of Campylobacter Jejuni in Avian and Human Hosts and in the Environment. International Journal of Infectious Diseases.2002,6, Supplement 3 (0):S16-S21
[40]L. Moran, P. Scates, R.H. Madden. Prevalence of Campylobacter Spp. In Raw Retail Poultry on Sale in Northern Ireland. Journal of Food Protection.2009,72 (9):1830-1835
[41]N.J. Stern, J.E. Line. Comparison of 3 Methods for Recovery of Campylobacter Spp from Broiler Carcasses. Journal of Food Protection.1992,55 (9):663-666
[42]A.W. van de Giessen, B.P. Bloemberg, W.S. Ritmeester, et al. Epidemiological Study on Risk Factors and Risk Reducing Measures for Campylobacter Infections in Dutch Broiler Flocks. Epidemiology and Infection.1996,117 (2):245-250
[43]R.H. Mdegela, H.E. Nonga, H.A. Ngowi, et al. Prevalence of Thermophilic Campylobacter Infections in Humans, Chickens and Crows in Morogoro, Tanzania. Journal of Veterinary Medicine Series B-infectious Diseases and Veterinary Public Health.2006,53 (3):116-121
[44]J. Anderson, B.J. Horn, B.J. Gilpin. The Prevalence and Genetic Diversity of Campylobacter Spp. In Domestic 'Backyard' Poultry in Canterbury, New Zealand. Zoonoses Public Health.2011
[45]X. Chen, G.W. Naren, C.M. Wu, et al. Prevalence and Antimicrobial Resistance of Campylobacter Isolates in Broilers from China. Veterinary Microbiology.2010,144 (1-2):133-139
[46]R. Takahashi, F. Shahada, T. Chuma, et al. Analysis of Campylobacter Spp. Contamination in Broilers from the Farm to the Final Meat Cuts by Using Restriction Fragment Length Polymorphism of the Polymerase Chain Reaction Products. International Journal of Food Microbiology.2006,110 (3): 240-245
[47]Y. Ghafir, B. China, K. Dierick, et al. A Seven-Year Survey of Campylobacter Contamination in Meat at Different Production Stages in Belgium. International Journal of Food Microbiology.2007, 116(1):111-120
[48]J.E.L. Corry, H.I. Atabay. Poultry as a Source of Campylobacter and Related Organisms. Journal of Applied Microbiology.2001,90:96s-114s
[49]J.E. Corry, H.I. Atabay. Poultry as a Source of Campylobacter and Related Organisms. Symposium series (Society for Applied Microbiology).2001 (30):96S-114S
[50]O.M. Cloak, G. Duffy, J.J. Sheridan, et al. A Survey on the Incidence of Campylobacter Spp. And the Development of a Surface Adhesion Polymerase Chain Reaction (Sa-Pcr) Assay for the Detection of Campylobacter Jejuni in Retail Meat Products. Food Microbiology.2001,18 (3):287-298
[51]T. Humphrey, S. O'Brien, M. Madsen. Campylobacters as Zoonotic Pathogens:A Food Production Perspective. International Journal of Food Microbiology.2007,117 (3):237-257
[52]V. Atanassova, C. Ring. Prevalence of Campylobacter Spp. In Poultry and Poultry Meat in Germany. International Journal of Food Microbiology.1999,51 (2-3):187-190
[53]N.J. Stern, M.C. Robach. Enumeration of Campylobacter Spp. In Broiler Feces and in Corresponding Processed Carcasses. Journal of Food Protection.2003,66 (9):1557-1563
[54]Q.H. Luu, T.H. Tran, D.C. Phung, et al. Study on the Prevalence of Campylobacter Spp. From Chicken Meat in Hanoi, Vietnam. Annals of the New York Academy of Sciences.2006,1081:273-275
[55]R.J. Meldrum, I.G. Wilson. Salmonella and Campylobacter in United Kingdom Retail Raw Chicken in 2005. Journal of Food Protection.2007,70 (8):1937-1939
[56]S. Cui, B. Ge, J. Zheng, et al. Prevalence and Antimicrobial Resistance of Campylobacter Spp. And Salmonella Serovars in Organic Chickens from Maryland Retail Stores. Applied and Environmental Microbiology.2005,71 (7):4108-4111
[57]F. Han, S.I. Lestari, S. Pu, et al. Prevalence and Antimicrobial Resistance among Campylobacter Spp. In Louisiana Retail Chickens after the Enrofloxacin Ban. Foodborne Pathogens and Disease.2009,6 (2):163-171
[58]H. Suzuki, S. Yamamoto. Campylobacter Contamination in Retail Poultry Meats and by-Products in the World:A Literature Survey. Journal of Veterinary Medical Science.2009,71 (3): 255-261
[59]T.L. Wong, L. Hollis, A. Cornelius, et al. Prevalence, Numbers, and Subtypes of Campylobacter Jejuni and Campylobacter Coli in Uncooked Retail Meat Samples. Journal of Food Protection.2007,70 (3):566-573
[60]P. Mullner, J.M. Collins-Emerson, A.C. Midwinter, et al. Molecular Epidemiology of Campylobacter Jejuni in a Geographically Isolated Country with a Uniquely Structured Poultry Industry. Applied and Environmental Microbiology.2010,76 (7):2145-2154
[61]C. Yang, Y. Jiang, K. Huang, et al. Application of Real-Time Pcr for Quantitative Detection of Campylobacter Jejuni in Poultry, Milk and Environmental Water. FEMS Immunology and Medical Microbiology.2003,38 (3):265-271
[62]袁标,吴开富,刘德超等.应用PCR技术快速检测禽肉中弯曲菌.肉类工业.2010(04)：43-45
[63]焦扬,翟伟华,黄金林.鸡肉屠宰加工环节弯曲菌流行病学调查与分析.肉类工业.2011(04)：44-46
[64]N. Luo, S. Pereira, O. Sahin, et al. Enhanced in Vivo Fitness of Fluoroquinolone-Resistant Campylobacter Jejuni in the Absence of Antibiotic Selection Pressure. Proceedings of the National Academy of Sciences of the United States of America.2005,102 (3):541-546
[65]L.J. Piddock, V. Ricci, L. Pumbwe, et al. Fluoroquinolone Resistance in Campylobacter Species from Man and Animals:Detection of Mutations in Topoisomerase Genes. Journal of Antimicrobial Chemotherapy.2003,51 (1):19-26
[66]M. Yan, O. Sahin, J. Lin, et al. Role of the CmeABC Efflux Pump in the Emergence of Fluoroquinolone-Resistant Campylobacter under Selection Pressure. Journal of Antimicrobial Chemotherapy.2006,58 (6):1154-1159
[67]D. Acheson, B.M. Allos. Campylobacter Jejuni Infections:Update on Emerging Issues and Trends. Clinical Infectious Diseases.2001,32 (8):1201-1206
[68]M. Lehtopolku. Antimicrobial Resistance in Campylobacter Jejuni and Campylobacter Coli. 2011,http://www.doria.fi/bitstream/handle/10024/70812/AnnalesD976Lehtopolku.pdf?sequence=1
[69]S.S. Qin, C.M. Wu, Y. Wang, et al. Antimicrobial Resistance in Campylobacter Coli Isolated from Pigs in Two Provinces of China. International Journal of Food Microbiology.2011,146 (1):94-98
[70]许海燕,黄金林,包广宇等.扬州市区腹泻人群空肠弯曲菌和结肠弯曲菌流行状况及耐药性分析.中国人兽共患病学报.2008(1)：58-62
[71]张茂俊,张建中.空肠弯曲菌耐药现状.疾病监测.2007(12)：793-796+811
[72]M. Zhang, Y. Gu, L. He, et al. Molecular Typing and Antimicrobial Susceptibility Profiles of Campylobacter Jejuni Isolates from North China. Journal of Medical Microbiology.2010,59 (Pt 10): 1171-1177
[73]A. Gibreel, D.E. Taylor. Macrolide Resistance in Campylobacter Jejuni and Campylobacter Coli. Journal of Antimicrobial Chemotherapy.2006,58 (2):243-255
[74]D.B. Caldwell, Y. Wang, J. Lin. Development, Stability, and Molecular Mechanisms of Macrolide Resistance in Campylobacter Jejuni. Antimicrobial Agents and Chemotherapy.2008,52 (11): 3947-3954
[75]S. Qin, Y. Wang, Q. Zhang, et al. Report of Ribosomal RNA Methylase Gene erm (B) in Multidrug-Resistant Campylobacter Coli. Journal of Antimicrobial Chemotherapy.2013:492
[76]J. Lin, L.O. Michel, Q. Zhang. CmeABC Functions as a Multidrug Efflux System in Campylobacter Jejuni. Antimicrobial Agents and Chemotherapy.2002,46 (7):2124-2131
[77]S. Zhao, S.R. Young, E. Tong, et al. Antimicrobial Resistance of Campylobacter Isolates from Retail Meat in the United States between 2002 and 2007. Applied and Environmental Microbiology. 2010,76 (24):7949-7956
[78]A. Gibreel, D.M. Tracz, L. Nonaka, et al. Incidence of Antibiotic Resistance in Campylobacter Jejuni Isolated in Alberta, Canada, from 1999 to 2002, with Special Reference to Tet(O)-Mediated Tetracycline Resistance. Antimicrobial Agents and Chemotherapy.2004,48 (9): 3442-3450
[79]A. Gibreel, N.M. Wetsch, D.E. Taylor. Contribution of the CmeABC Efflux Pump to Macrolide and Tetracycline Resistance in Campylobacter Jejuni. Antimicrobial Agents and Chemotherapy.2007,51 (9):3212-3216
[80]J. Ruiz, F. Marco, I. Oliveira, et al. Trends in Antimicrobial Resistance in Campylobacter Spp. Causing Traveler's Diarrhea. Agricultural Production and Market Information System.2007,115 (3): 218-224
[81]M.M. Feizabadi, S. Dolatabadi, M.R. Zali. Isolation and Drug-resistant Patterns of Campylobacter Strains Cultured from Diarrheic Children in Tehran. Japanese journal of infectious diseases.2007,60 (4):217-219
[82]L. Scott, P. Menzies, R.J. Reid-Smith, et al. Antimicrobial Resistance in Campylobacter Spp. Isolated from Ontario Sheep Flocks and Associations between Antimicrobial Use and Antimicrobial Resistance. Zoonoses Public Health.2012,59 (4):294-301
[83]卢玲,郁庆福.不同来源的空肠弯曲菌对20种抗生素敏感性调查.中国人兽共患病杂志.1990(3)：45-46
[84]侯凤琴,沈宝铨,孙新婷.200株弯曲菌对抗生素敏感性研究.中华医院感染学杂志.2001,11(6)：406-408
[85]Q. Zhang, P.J. Plummer, I. Nachamkin, et al. Mechanisms of Antibiotic Resistance in Campylobacter. Campylobacter.2008 (3):263-276
[86]X.-Z. Li, M. Mehrotra, S. Ghimire, et al. P-Lactam Resistance and P-Lactamases in Bacteria of Animal Origin. Veterinary microbiology.2007,121 (3):197-214
[87]J. Wagner, M. Jabbusch, M. Eisenblatter, et al. Susceptibilities of Campylobacter Jejuni Isolates from Germany to Ciprofloxacin, Moxifloxacin, Erythromycin, Clindamycin, and Tetracycline. Antimicrobial Agents and Chemotherapy.2003,47 (7):2358-2361
[88]M. Cannon, S. Harford, J. Davies. A Comparative Study on the Inhibitory Actions of Chloramphenicol, Thiamphenicol and Some Fluorinated Derivatives. Journal of Antimicrobial Chemotherapy.1990,26 (3):307-317
[89]CAC. Principles and Guidelines for the Conduct of Microbiological Risk Assessment. CAC/GL.1999,30:1-6
[90]D. Vose, J. Acar, F. Anthony, et al. Antimicrobial Resistance:Risk Analysis Methodology for the Potential Impact on Public Health of Antimicrobial Resistant Bacteria of Animal Origin. International Office of Epizootics.2001,20 (3):811-827
[91]E. Snary, S. McEwen, L. Guardabassi, et al. Antimicrobial Resistance Risk Assessment. Guide to Antimicrobial Use in Animals.2008:27
[92]S. Forsythe. The Microbiological Risk Assessment of Food. Wiley Online Library,2007
[93]WHO. Hazard Characterization for Pathogens in Food and Water:Guidelines. Food and Agriculture Organization of the United Nations,2003
[94]A.M. Lammerding, A. Fazil. Hazard Identification and Exposure Assessment for Microbial Food Safety Risk Assessment. International Journal of Food Microbiology.2000,58 (3):147-157
[95]CAC. Proposed Draft Guidelines for Risk Analysis of Foodborne Antimicrobial Resistance. Jeju, Republic of Korea,12-16 October 2009
[96]D. Vose. Risk Analysis:A Quantitative Guide. John Wiley & Sons,2008
[97]D. Burch. Risk Assessment-Campylobacter Infection Transmission from Pigs to Man Using Erythromycin Resistance as a Marker. Pig Journal.2002,50:53-58
[98]F. Moutou, B. Dufour, Y. Ivanov. A Qualitative Assessment of the Risk of Introducing Foot and Mouth Disease into Russia and Europe from Georgia, Armenia and Azerbaijan. International Office of Epizootics.2001,20 (3):723-730
[99]FDA. Guidance for Industry 152:Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern. Rockville, Md, 2003
[100]M. Coleman, H. Marks. Qualitative and Quantitative Risk Assessment. Food Control.1999, 10 (4):289-297
[101]H.S. Hurd, S. Doores, D. Hayes, et al. Public Health Consequences of Macrolide Use in Food Animals:A Deterministic Risk Assessment. Journal of Food Protection.2004,67 (5):980-992
[102]F.O. Hoffman, S. Kaplan. Beyond the Domain of Direct Observation:How to Specify a Probability Distribution That Represents the "State of Knowledge" About Uncertain Inputs. Risk Analysis.1999,19(1):131-134
[103]A.C. Davison. Bootstrap Methods and Their Application. Cambridge university press,1997
[104]A. Gelman, J.B. Carlin, H.S. Stern, et al. Bayesian Data Analysis. CRC press,2013
[105]D.F. Groebner, P.W. Shannon, P.C. Fry, et al. Business Statistics:A Decision Making Approach. Prentice Hall/Pearson,2011
[106]E.L. Snary, L.A. Kelly, H.C. Davison, et al. Antimicrobial Resistance:A Microbial Risk Assessment Perspective. Journal of Antimicrobial Chemotherapy.2004,53 (6):906-917
[107]L. Alban, E.O. Nielsen, J. Dahl. A Human Health Risk Assessment for Macrolide-Resistant Campylobacter Associated with the Use of Macrolides in Danish Pig Production. Preventive Veterinary Medicine.2008,83 (2):115-129
[108]L.A. Cox, Jr., D.A. Popken. Assessing Potential Human Health Hazards and Benefits from Subtherapeutic Antibiotics in the United States:Tetracyclines as a Case Study. Risk Analysis.2010,30 (3):432-457
[109]S.A. Anderson, R.W. Yeaton Woo, L.M. Crawford. Risk Assessment of the Impact on Human Health of Resistant Campylobacter Jejuni from Fluoroquinolone Use in Beef Cattle. Food Control.2001,12(1):13-25
[110]H.S. Hurd, C. Enoe, L. Sorensen, et al. A Stochastic Assessment of the Public Health Risks of the Use of Macrolide Antibiotics in Food Animals. Risk Analysis.2008,28 (3):695-710
[111]L.A.T. Cox, D.A. Popken. Quantifying Potential Human Health Impacts of Animal Antibiotic Use:Enrofloxacin and Macrolides in Chickens. Risk Analysis.2006,26 (1):135-146
[112]FDA-CVM. The Human Health Impact of Fluoroquinolone Resistant Campylobacter Attributed to the Consumption of Chicken.2000, http://www.fda.gov/downloads/AnimalVeterinary/SafetyHealth/RecallsWithdrawals/UCM152308.pdf
[113]B. Melero, P. Juntunen, M.L. Hanninen, et al. Tracing Campylobacter Jejuni Strains Along the Poultry Meat Production Chain from Farm to Retail by Pulsed-Field Gel Electrophoresis, and the Antimicrobial Resistance of Isolates. Food Microbiology.2012,32 (1):124-128
[114]D. Linton, A.J. Lawson, R.J. Owen, et al. Pcr Detection, Identification to Species Level, and Fingerprinting of Campylobacter Jejuni and Campylobacter Coli Direct from Diarrheic Samples. Journal of Clinical Microbiology.1997,35 (10):2568-2572
[115]G. Keramas, D.D. Bang, M. Lund, et al. Development of a Sensitive DNA Microarray Suitable for Rapid Detection of Campylobacter Spp. Molecular and Cellular Probes.2003,17 (4): 187-196
[116]CLSI. Institute. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Informational Supplement. Clinical and Laboratory Standards Institute, Wayne,PA.2008, CLSI Document M31-A3
[117]S. Park. The Physiology of Campylobacter Species and Its Relevance to Their Role as Foodborne Pathogens. International Journal of Food Microbiology.2002,74 (3):177
[118]T.M. Osaili, A.R. Alaboudi, R.R. Al-Akhras. Prevalence and Antimicrobial Susceptibility of Campylobacter Spp. In Live and Dressed Chicken in Jordan. Foodborne Pathogens and Disease.2011
[119]王娟,黄秀梅,刘书科等.不同动物源大肠杆菌的耐药性监测分析.中国兽医杂志.2013,49(11)：64-67
[120]M. Skirrow. Campylobacter Enteritis:A" New" Disease. British Medical Journal.1977,2 (6078):9
[121]F. Bolton, D. Coates, D. Hutchinson. The Ability of Campylobacter Media Supplements to Neutralize Photochemically Induced Toxicity and Hydrogen Peroxide. Journal of Applied Microbiology. 1984,56(1):151-157
[122]J.E. Corry, D. Post, P. Colin, et al. Culture Media for the Isolation of Campylobacters. Progress in Industrial Microbiology.1995,34:129-162
[123]F. Bolton, D. Coates, P. Hinchliffe, et al. Comparison of Selective Media for Isolation of Campylobacter Jejuni/Coli. Journal of Clinical Pathology.1983,36 (1):78-83
[124]C. Baylis, S. MacPhee, K. Martin, et al. Comparison of Three Enrichment Media for the Isolation of Campylobacter Spp. From Foods. Journal of Applied Microbiology.2000,89 (5):884-891
[125]B.G. Meerburg, A. Kijlstra. Role of Rodents in Transmission of Salmonella and Campylobacter. Journal of the Science of Food and Agriculture.2007,87 (15):2774-2781
[126]M. Hofshagen, H. Kruse. Reduction in Flock Prevalence of Campylobacter Spp. In Broilers in Norway after Implementation of an Action Plan. Journal of Food Protection.2005,68 (10): 2220-2223
[127]H. Hariharan, S. Sharma, A. Chikweto, et al. Antimicrobial Drug Resistance as Determined by the E-Test in Campylobacter Jejuni, C. Coli, and C. Lari Isolates from the Ceca of Broiler and Layer Chickens in Grenada. Comparative Immunology, Microbiology and Infectious Diseases.2009,32 (1): 21-28
[128]I. Henry, J. Reichardt, M. Denis, et al. Prevalence and Risk Factors for Campylobacter Spp. In Chicken Broiler Flocks in Reunion Island (Indian Ocean). Preventive Veterinary Medicine.2011, 100 (1):64-70
[129]I. Damjanova, M. Jakab, T. Farkas, et al. From Farm to Fork Follow-up of Thermotolerant Campylobacters Throughout the Broiler Production Chain and in Human Cases in a Hungarian County During a Ten-Months Period. International Journal of Food Microbiology.2011,150 (2):95-102
[130]D. Ewnetu, A. Mihret. Prevalence and Antimicrobial Resistance of Campylobacter Isolates from Humans and Chickens in Bahir Dar, Ethiopia. Foodborne Pathogens and Disease.2010,7 (6): 667-670
[131]F. Han, S.I. Lestari, S. Pu, et al. Prevalence and Antimicrobial Resistance among Campylobacter Spp. In Louisiana Retail Chickens after the Enrofloxacin Ban. Foodborne Pathogens and Disease.2009,6 (2):163-171
[132]Y.-S. Kang, Y.-S. Cho, S.-K. Yoon, et al. Prevalence and Antimicrobial Resistance of Campylobacter Jejuni and Campylobacter Coli Isolated from Raw Chicken Meat and Human Stools in Korea. Journal of Food Protection.2006,69 (12):2915-2923
[133]M. Norstrom, G. Johnsen, M. Hofshagen, et al. Antimicrobial Resistance in Campylobacter Jejuni from Broilers and Broiler House Environments in Norway. Journal of Food Protection.2007,70 (3):736-738
[134]唐雪莲,佟恒敏.喹诺酮类药物研究进展及在兽医临床的应用问题.黑龙江畜牧兽医.2001(03)：24-26
[135]L.B. Price, E. Johnson, R. Vailes, et al. Fluoroquinolone-Resistant Campylobacter Isolates from Conventional and Antibiotic-Free Chicken Products. Environmental Health Perspectives.2005, 113 (5):557-560
[136]M.J. Albert, E. Udo, B.T. Jose, et al. Tetracycline Resistance Is Frequent among Campylobacter Jejuni Isolates from Kuwait. Microbial Drug Resistance.2009,15 (2):115-120
[137]P. Juntunen, T. Laurila, M. Heinonen, et al. Absence of Tetracycline Resistance in Campylobacter Coli Isolates from Finnish Finishing Pigs Treated with Chlortetracycline. Journal of Applied Microbiology.2013,114 (4):974-981
[138]J.I. Dasti, U. Groβ, S. Pohl, et al. Role of the Plasmid-Encoded Tet (O) Gene in Tetracycline-Resistant Clinical Isolates of Campylobacter Jejuni and Campylobacter Coli. Journal of Medical Microbiology.2007,56 (6):833-837
[139]A. Noormohamed, M.K. Fakhr. Incidence and Antimicrobial Resistance Profiling of Campylobacter in Retail Chicken Livers and Gizzards. Foodbome Pathogens and Disease.2012,9 (7): 617-624
[140]A. Thibodeau, P. Fravalo, S. Laurent-Lewandowski, et al. Presence and Characterization of Campylobacter Jejuni in Organically Raised Chickens in Quebec. Canadian Journal of Veterinary Research.2011,75 (4):298-307
[141]B.M. Allos, M.J. Blaser. Campylobacter Jejuni and the Expanding Spectrum of Related Infections. Clinical Infectious Diseases.1995,20 (5):1092-1099; 1100-1091
[142]A.S. Obeng, H. Rickard, M. Sexton, et al. Antimicrobial Susceptibilities and Resistance Genes in Campylobacter Strains Isolated from Poultry and Pigs in Australia. Journal of Applied Microbiology.2012,113 (2):294-307
[143]E. Shin, Y. Oh, M. Kim, et al. Antimicrobial Resistance Patterns and Corresponding Multilocus Sequence Types of the Campylobacter Jejuni Isolates from Human Diarrheal Samples. Microbial Drug Resistance.2012
[144]W. Mattheus, N. Botteldoorn, K. Heylen, et al. Trend Analysis of Antimicrobial Resistance in Campylobacter Jejuni and Campylobacter Coli Isolated from Belgian Pork and Poultry Meat Products Using Surveillance Data of 2004-2009. Foodborne Pathogens and Disease.2012,9 (5): 465-472
[145]D.E. Taylor, D.M. Tracz. Mechanisms of Antimicrobial Resistance in Campylobacter. Campylobacter Molecular and Cell Biology.2005:193-204
[146]王加才,万荣峰,江善祥.超微粉碎对氟苯尼考在肉鸡体内药动学的影响.中国兽药杂志.2008,42(2)：32-35
[147]L. Ma, Z. Shen, G. Naren, et al. Identification of a Novel G2073a Mutation in 23s Rrna in Amphenicol-Selected Mutants of Campylobacter Jejuni. PLoS One.2014,9 (4):e94503
[148]A. Noormohamed, M.K. Fakhr. A Higher Prevalence Rate of Campylobacter in Retail Beef Livers Compared to Other Beef and Pork Meat Cuts. International Journal of Environmental Research and Public Health.2013,10 (5):2058-2068
[149]A. Deckert, A. Valdivieso-Garcia, R. Reid-Smith, et al. Prevalence and Antimicrobial Resistance in Campylobacter Spp. Isolated from Retail Chicken in Two Health Units in Ontario. Journal of Food Protection.2010,73 (7):1317-1324
[150]Y.S. Kang, Y.S. Cho, S.K. Yoon, et al. Prevalence and Antimicrobial Resistance of Campylobacter Jejuni and Campylobacter Coli Isolated from Raw Chicken Meat and Human Stools in Korea. Journal of Food Protection.2006,69 (12):2915-2923
[151]N.P. Varela, R. Friendship, C. Dewey. Prevalence of Resistance to 11 Antimicrobials among Campylobacter Coill Isolated from Pigs on 80 Grower-Finisher Farms in Ontario. Canadian Journal of Veterinary Research.2007,71 (3):189-194
[152]L.-P. Potturi-Venkata, S. Backert, S.L. Vieira, et al. Evaluation of Logistic Processing to Reduce Cross-Contamination of Commercial Broiler Carcasses with Campylobacter Spp. Journal of Food Protection.2007,70 (11):2549-2554
[153]K.T. Elvers, V.K. Morris, D.G. Newell, et al. Molecular Tracking, through Processing, of Campylobacter Strains Colonizing Broiler Flocks. Applied and Environmental Microbiology.2011,77 (16):5722-5729
[154]G. Johnsen, H. Kruse, M. Hofshagen. Genotyping of Thermotolerant Campylobacter from Poultry Slaughterhouse by Amplified Fragment Length Polymorphism. Journal of Applied Microbiology.2007,103 (2):271-279
[155]P. Luber, E. Bartelt. Enumeration of Campylobacter Spp. On the Surface and within Chicken Breast Fillets. Journal of Applied Microbiology.2007,102 (2):313-318
[156]李继昌,鲁成武,符春燕等.氟喹诺酮类药物在禽病防治上的应用.黑龙江畜牧兽医.1998,10：27
[157]H.S. Hurd, S. Doores, D. Hayes, et al. Public Health Consequences of Macrolide Use in Food Animals:A Deterministic Risk Assessment. Journal of Food Protection.2004,67 (5):980-992
[158]许紫建.猪、鸡弯曲菌的分离鉴定和耐药性分析及空肠弯曲菌Lamp检测方法的研究[硕士]：河北农业大学.2013
[159]Ministry of Agriculture, Forestry and Fisheries. A Report on the Japanese Veterinary Antimicrobial Resistance Monitoring System 2000 to 2007.2009, http://www.maff.go.jp/nval/english/pdf/jvarm2000_2007_final_201005.pdf
[160]A.A. Delsol, J. Sunderland, M.J. Woodward, et al. Emergence of Fluoroquinolone Resistance in the Native Campylobacter Coli Population of Pigs Exposed to Enrofloxacin. Journal of Antimicrobial Chemotherapy.2004,53 (5):872-874
[161]F.M. Aarestrup, E.M. Nielsen, M. Madsen, et al. Antimicrobial Susceptibility Patterns of Thermophilic Campylobacter Spp. From Humans, Pigs, Cattle, and Broilers in Denmark. Antimicrobial Agents and Chemotherapy.1997,41(10):2244-2250
[162]司徒潮满,赖植发,张勇等.深圳市售活禽空肠弯曲菌带菌及禽肉污染状况调查.华南预防医学.2011,37(2)：48-48
[163]J. Boes, L. Nersting, E.M. Nielsen, et al. Prevalence and Diversity of Campylobacter Jejuni in Pig Herds on Farms with and without Cattle or Poultry. Journal of Food Protection.2005,68 (4): 722-727
[164]D. Taylor, L. Ng, H. Lior. Susceptibility of Campylobacter Species to Nalidixic Acid, Enoxacin, and Other DNA Gyrase Inhibitors. Antimicrobial Agents and Chemotherapy.1985,28 (5): 708-710
[165]T.D. Gootz, B.A. Martin. Characterization of High-Level Quinolone Resistance in Campylobacter Jejuni. Antimicrobial Agents and Chemotherapy.1991,35 (5):840-845
[166]P.F. McDermott, S.M. Bodeis, L.L. English, et al. Ciprofloxacin Resistance in Campylobacter Jejuni Evolves Rapidly in Chickens Treated with Fluoroquinolones. Journal of Infectious Diseases.2002,185 (6):837-840
[167]N. Luo, O. Sahin, J. Lin, et al. In Vivo Selection of Campylobacter Isolates with High Levels of Fluoroquinolone Resistance Associated with Gyra Mutations and the Function of the Cmeabc Efflux Pump. Antimicrobial Agents and Chemotherapy.2003,47 (1):390-394
[168]M. van Boven, K.T. Veldman, M.C. de Jong, et al. Rapid Selection of Quinolone Resistance in Campylobacter Jejuni but Not in Escherichia Coli in Individually Housed Broilers. Journal of Antimicrobial Chemotherapy.2003,52 (4):719-723
[169]尹彦勋,罗平涛.中国肉鸡产业的发展现状及趋势.全球肉鸡产业论坛暨第二届中国白羽肉鸡产业发展大会会刊.2010
[170]辛翔飞,刘春芳,王济民.我国肉鸡产业发展现状、问题与对策.中国家禽.2011(04)：6-9
[171]王济民,申秋红,张瑞荣.中国肉鸡产业发展趋势.今日畜牧兽医.2010(06)：1-3
[172]高俊岭,李玫.1994-2014年全球鸡肉供需和产量回顾与预测.饲料广角.2005(17)：40-42
[173]王振国,罗雁菲,肖成蕊等.鸡肉中弯曲杆菌属的分离与鉴定.中国畜产与食品.2005,7(2)：53-54
[174]M.S. Dryden, R.J. Gabb, S.K. Wright. Empirical Treatment of Severe Acute Community-Acquired Gastroenteritis with Ciprofloxacin. Clinical Infectious Diseases.1996,22 (6): 1019-1025
[175]M. Sessmentseries. Risk Assessment of Campylobacter Spp. In Broiler Chickens.2009
[176]王君,刘秀梅,郭云昌.鸡肉空肠弯曲菌标准制定过程中风险评估的应用.卫生研究.2010(05)：563-566
[177]沈和萍,吴蔚.小儿空肠弯曲菌肠炎534例分析.中国儿童保健杂志.2007,14(6)：640-641
[178]J.W. Sanders, D.W. Isenbarger, S.E. Walz, et al. An Observational Clinic-Based Study of Diarrheal Illness in Deployed United States Military Personnel in Thailand:Presentation and Outcome of Campylobacter Infection. American Journal of Tropical Medicine and Hygiene.2002,67 (5): 533-538
[179]H.L. DuPont. Use of Quinolones in the Treatment of Gastrointestinal Infections. European Journal of Clinical Microbiology and Infectious Diseases.1991,10 (4):325-329
[180]B.T. Solow, O.M. Cloak, P.M. Fratamico. Effect of Temperature on Viability of Campylobacter Jejuni and Campylobacter Coli on Raw Chicken or Pork Skin. Journal of Food Protection.2003,66 (11):2023-2031
[181]E.K. Jagusztyn-Krynicka, P. Laniewski, A. Wyszynska. Update on Campylobacter Jejuni Vaccine Development for Preventing Human Campylobacteriosis. Expert Review of Vaccines.2009,8 (5):625-645
[182]C.C. Tam, S.J. O'Brien, I. Petersen, et al. Guillain-Barre Syndrome and Preceding Infection with Campylobacter, Influenza and Epstein-Barr Virus in the General Practice Research Database. PLoS One.2007,2 (4):e344
[183]杨国昌.甲氟哌酸的抗菌活性、药理和临床应用.国外医药(抗生素分册).1990(02)：129-135
[184]梁诚.氟喹诺酮类药物生产现状与研究进展.精细与专用化学品.2005(05)：1-4
[185]H.P. Endtz, G.J. Ruijs, B. van Klingeren, et al. Quinolone Resistance in Campylobacter Isolated from Man and Poultry Following the Introduction of Fluoroquinolones in Veterinary Medicine. Journal of Antimicrobial Chemotherapy.1991,27 (2):199-208
[186]P.N. Gaunt, L.J. Piddock. Ciprofloxacin Resistant Campylobacter Spp. In Humans:An Epidemiological and Laboratory Study. Journal of Antimicrobial Chemotherapy.1996,37 (4):747-757
[187]P.N. Gaunt, L.J.V. Piddock. Ciprofloxacin Resistant Campylobacter Spp. In Humans:An Epidemiological and Laboratory Study. Journal of Antimicrobial Chemotherapy.1996,37 (4):747-757
[188]崔生辉,李景云,马越.细菌对氟喹诺酮类药物的耐药机制.中国药房.2007(02)：148-150
[189]H. Yang, S. Chen, D.G. White, et al. Characterization of Multiple-Antimicrobial-Resistant Escherichia Coli Isolates from Diseased Chickens and Swine in China. Journal of Clinical Microbiology.2004,42 (8):3483-3489
[190]S. Cui, B. Ge, J. Zheng, et al. Prevalence and Antimicrobial Resistance of Campylobacter Spp. And Salmonella Serovars in Organic Chickens from Maryland Retail Stores. Applied and Environmental Microbiology.2005,71 (7):4108-4111
[191]S. Bagel, V. Hullen, B. Wiedemann, et al. Impact of Gyra and Parc Mutations on Quinolone Resistance, Doubling Time, and Supercoiling Degree of Escherichia Coli. Antimicrobial Agents and Chemotherapy.1999,43 (4):868-875
[192]Q. Zhang, O. Sahin, P.F. McDermott, et al. Fitness of Antimicrobial-Resistant Campylobacter and Salmonella. Microbes and Infection.2006,8 (7):1972-1978
[193]王明华.Qnr介导细菌对喹诺酮类耐药机制的研究[博士]：复旦大学.2010
[194]L.J. Piddock. Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria. Clinical Microbiology Reviews.2006,19 (2):382-402
[195]J. Bjorkman, D.I. Andersson. The Cost of Antibiotic Resistance from a Bacterial Perspective. Drug Resistance Updates.2000,3 (4):237-245
[196]N.D. Luo, S. Pereira, O. Sahin, et al. Enhanced in Vivo Fitness of Fluoroquinolone-Resistant Campylobacter Jejuni in the Absence of Antibiotic Selection Pressure. Proceedings of the National Academy of Sciences of the United States of America.2005,102 (3):541-546
[197]L.B. Price, E. Johnson, R. Vailes, et al. Fluoroquinolone-Resistant Campylobacter Isolates from Conventional and Antibiotic-Free Chicken Products. Environmental Health Perspectives.2005, 113 (5):557-560
[198]K. Pedersen, A. Wedderkopp. Resistance to Quinolones in Campylobacter Jejuni and Campylobacter Coli from Danish Broilers at Farm Level. Journal of Applied Microbiology.2003,94 (1):111-119
[199]K.E. Smith, J.M. Besser, C.W. Hedberg, et al. Quinolone-Resistant Campylobacter Jejuni Infections in Minnesota,1992-1998. Investigation Team. The New England Journal of Medicine.1999, 340(20):1525-1532
[200]J. Reina, N. Borrell, A. Serra. Emergence of Resistance to Erythromycin and Fluoroquinolones in Thermotolerant Campylobacter Strains Isolated from Feces 1987-1991. European Journal of Clinical Microbiology and Infectious Diseases.1992,11 (12):1163-1166
[201]R. Sanchez, V. Fernandez-Baca, M.D. Diaz, et al. Evolution of Susceptibilities of Campylobacter Spp. To Quinolones and Macrolides. Antimicrobial Agents and Chemotherapy.1994, 38(9):1879-1882
[202]H. Endtz, R.P. Mouton, T. Van Der Reyden, et al. Fluoroquinolone Resistance in Campylobacter Spp Isolated from Human Stools and Poultry Products. The Lancet.1990,335 (8692): 787
[203]乔昕,袁宝君,吴高林.南京市2006年鸡肉产品中空肠弯曲菌污染状况调查.江苏预防医学.2007,18(2)：37-38
[204]徐君怡,曹际娟,郑秋月等.多重Pcr-变性高效液相色谱检测食品中空肠弯曲菌和结肠弯曲菌.中国预防兽医学报.2009,31(3)：207-212
[205]L. Desheng, C. Zhixin, W. Bolun. Age Distribution of Diarrhoeal and Healthy Children Infected with Campylobacter Jejuni. Journal of Tropical Medicine and Hygiene.1992,95 (3):218-220
[206]J. Chen, X.T. Sun, Z. Zeng, et al. Campylobacter Enteritis in Adult Patients with Acute Diarrhea from 2005 to 2009 in Beijing, China. Chinese Medical Journal.2011,124 (10):1508-1512
[207]蒋龙芳,汪芬娟,汪永良等.杭州市萧山区人群腹泻病发病及就诊现况分析.中国自然医学杂志.2010(03)：198-200
[208]金立坚,袁珩,张辉等.四川省腹泻病现状调查.预防医学情报杂志.2009(03)：183-186
[209]梁大斌,林玫,李永红等.广西城乡腹泻病调查病例临床特征分析.中国热带医学.2009(04)：659-660
[210]柴程良.腹泻病流行特征与经济负担研究[硕士]：浙江大学.2010
[211]杨建军.甘肃省腹泻病流行特征和经济负担研究[硕士]：中国疾病预防控制中心.2008
[212]侯凤琴,孙新婷,王贵强.教学医院不合理应用抗菌药物治疗成人急性感染性腹泻调查.中国药学.2010(03)：229-234
[213]李霖,周国民.131例小儿腹泻患者住院治疗回顾性分析.检验医学与临床.2010(02)：106-107+110
[214]徐琴,潘艳萍.2008～2009年淄博市淄川区腹泻病监测分析.预防医学论坛.2011(04)：339-340+343
[215]罗宏丽,肖顺林,王国俊.180例小儿急性腹泻病住院患者抗菌药物应用分析.中国药物应用与监测.2011(05)：306-308
[216]周志衡,王家骥,钟永煜等.粤西地区基层医院小儿腹泻病抗生素使用情况分析.中国热带医学.2006(08)：1511-1512
[217]缪晓辉,张元浩.感染性腹泻的治疗：选择与放弃.中国全科医学：医生读者版.2011,14(6)：30-32
[218]L.V. Piddock. Quinolone Resistance and Campylobacter. Clinical Microbiology and Infection.1999 (5):239-243
[219]C. Pigrau, R. Bartolome, B. Almirante, et al. Bacteremia Due to Campylobacter Species: Clinical Findings and Antimicrobial Susceptibility Patterns. Clinical Infectious Diseases.1997,25 (6): 1414-1420
[220]B.M. Korczak, M. Zurfluh, S. Emler, et al. Multiplex Strategy for Multilocus Sequence Typing, Fla Typing, and Genetic Determination of Antimicrobial Resistance of Campylobacter Jejuni and Campylobacter Coli Isolates Collected in Switzerland. Journal of Clinical Microbiology.2009,47 (7):1996-2007
[221]O. Hue, V. Allain, M.J. Laisney, et al. Campylobacter Contamination of Broiler Caeca and Carcasses at the Slaughterhouse and Correlation with Salmonella Contamination. Food Microbiology. 2011,28 (5):862-868
[222]H. Hilmarsson, H. Thormar, J.H. Thrainsson, et al. Effect of Glycerol Monocaprate (Monocaprin) on Broiler Chickens:An Attempt at Reducing Intestinal Campylobacter Infection. Poultry Science.2006,85 (4):588-592
[223]J. Ellis-Iversen, F. Jorgensen, S. Bull, et al. Risk Factors for Campylobacter Colonisation During Rearing of Broiler Flocks in Great Britain. Preventive Veterinary Medicine.2009,89 (3-4): 178-184
[224]D. Hermans, A. Martel, K. Van Deun, et al. Intestinal Mucus Protects Campylobacter Jejuni in the Ceca of Colonized Broiler Chickens against the Bactericidal Effects of Medium-Chain Fatty Acids. Poultry Science.2010,89 (6):1144-1155
[225]M.M. Cowan. Plant Products as Antimicrobial Agents. Clinical Microbiology Reviews.1999, 12 (4):564-82
[226]D. Hermans, A. Martel, K. van Deun, et al. The Cinnamon-Oil Ingredient Trans-Cinnamaldehyde Fails to Target Campylobacter Jejuni Strain Kc 40 in the Broiler Chicken Cecum Despite Marked in Vitro Activity. Journal of Food Protection.2011,74 (10):1729-1734
[227]J.A. Wagenaar, M.A.P.V. Bergen, M.A. Mueller, et al. Phage Therapy Reduces Campylobacter jejuni Colonization in Broilers. Veterinary Microbiology.2005,109 (3-4):275-283
[228]D. Hermans, K. Van Deun, W. Messens, et al. Campylobacter Control in Poultry by Current Intervention Measures Ineffective:Urgent Need for Intensified Fundamental Research. Veterinary Microbiology.2011,152 (3-4):219-228
[229]M.J. Nauta, F.J. van der Wal, F.F. Putirulan, et al. Evaluation of the "Testing and Scheduling" Strategy for Control of Campylobacter in Broiler Meat in the Netherlands. International Journal of Food Microbiology.2009,134 (3):216-222
[230]L. Herman, M. Heyndrickx, K. Grijspeerdt, et al. Routes for Campylobacter Contamination of Poultry Meat:Epidemiological Study from Hatchery to Slaughterhouse. Epidemiology and Infection. 2003,131(3):1169-1180
[231]M. Uyttendaele, K. Baert, Y. Ghafir, et al. Quantitative Risk Assessment of Campylobacter Spp. In Poultry Based Meat Preparations as One of the Factors to Support the Development of Risk-Based Microbiological Criteria in Belgium. International Journal of Food Microbiology.2006,111 (2):149-163
[232]L.C. Rodrigues, J.M. Cowden, J.G. Wheeler, et al. The Study of Infectious Intestinal Disease in England:Risk Factors for Cases of Infectious Intestinal Disease with Campylobacter Jejuni Infection. Epidemiology and Infection.2001,127 (2):185-193
[233]D.J. Griggs, M.M. Johnson, J.A. Frost, et al. Incidence and Mechanism of Ciprofloxacin Resistance in Campylobacter Spp. Isolated from Commercial Poultry Flocks in the United Kingdom before, During, and after Fluoroquinolone Treatment. Antimicrobial Agents and Chemotherapy.2005, 49 (2):699-707
[2]F.F. Barrett, R.F. McGehee Jr, M. Finland. Methicillin-Resistant Staphylococcus Aureus at Boston City Hospital:Bacteriologic and Epidemiologic Observations. New England Journal of Medicine.1968,279 (9):441-448
[3]R. Wise. Antimicrobial Resistance:Priorities for Action. Journal of Antimicrobial Chemotherapy.2002,49 (4):585-586
[4]J. Carlet, J.L. Mainardi. Antibacterial Agents:Back to the Future? Can We Live with Only Colistin, Co-Trimoxazole and Fosfomycin? Clinical Microbiology and Infection.2012,18 (1):1-3
[5]C. Gagliotti, A. Balode, F. Baquero, et al. Escherichia Coli and Staphylococcus Aureus:Bad News and Good News from the European Antimicrobial Resistance Surveillance Network (Ears-Net, Formerly Earss),2002 to 2009.2011
[6]T.R. Walsh, J. Weeks, D.M. Livermore, et al. Dissemination of Ndm-1 Positive Bacteria in the New Delhi Environment and Its Implications for Human Health:An Environmental Point Prevalence Study. The Lancet infectious diseases.2011,11 (5):355-362
[7]W. Couet, N. Gregoire, S. Marchand, et al. Colistin Pharmacokinetics:The Fog Is Lifting. Clinical Microbiology and Infection.2012,18 (1):30-39
[8]J. Carlet, V. Jarlier, S. Harbarth, et al. Ready for a World without Antibiotics? The Pensieres Antibiotic Resistance Call to Action. Antimicrobial resistance and infection control.2012,1 (1):1-13
[9]R. Wise, T. Hart, O. Cars, et al. Antimicrobial Resistance:Is a Major Threat to Public Health. BMJ:British Medical Journal.1998,317 (7159):609
[10]F. Bager, M. Madsen, J. Christensen, et al. Avoparcin Used as a Growth Promoter Is Associated with the Occurrence of Vancomycin-Resistant Enterococcus Faecium on Danish Poultry and Pig Farms. Preventive Veterinary Medicine.1997,31 (1-2):95-112
[11]F.M. Aarestrup, B. Carstensen. Effect of Tylosin Used as a Growth Promoter on the Occurrence of Macrolide-Resistant Enterococci and Staphylococci in Pigs. Microbial Drug Resistance. 1998,4 (4):307-312
[12]J. Acar, M. Casewell, J. Freeman, et al. Avoparcin and Virginiamycin as Animal Growth Promoters:A Plea for Science in Decision-Making. Clinical Microbiology and Infection.2000,6 (9): 477-482
[13]FDA. Enrofloxacin for Poultry; Final Decision on Withdrawal of New Animal Drug Application Following Formal Evidentiary Public Hearing; Availability. FR Doc.2005:05-15224
[14]H.S. Hurd, S. Doores, D. Hayes, et al. Public Health Consequences of Macrolide Use in Food Animals:A Deterministic Risk Assessment. Journal of Food Protection.2004,67(5):980-992
[15]L.A. Cox, D.A. Popken. Quantifying Human Health Risks from Virginiamycin Used in Chickens. Risk Analysis.2004,24 (1):271-288
[16]L.A.T. Cox Jr, D.A. Popken, J.J. Mathers. Human Health Risk Assessment of Penicillin/Aminopenicillin Resistance in Enterococci Due to Penicillin Use in Food Animals. Risk Analysis.2009,29 (6):796-805
[17]G.M. Ruiz-Palacios. The Health Burden of Campylobacter Infection and the Impact of Antimicrobial Resistance:Playing Chicken. Clinical Infectious Diseases.2007,44 (5):701-703
[18]E. EFSA. Panel on Biological Hazards (Biohaz). Scientific Opinion on Quantification of the Risk Posed by Broiler Meat to Human Campylobacteriosis in the Eu. EFSA Journal.2010,8:1437
[19]B.M. Allos. Campylobacter Jejuni Infections:Update on Emerging Issues and Trends. Clinical Infectious Diseases.2001,32 (8):1201-1206
[20]J. Engberg, F.M. Aarestrup, D.E. Taylor, et al. Quinolone and Macrolide Resistance in Campylobacter Jejuni and C. Coli:Resistance Mechanisms and Trends in Human Isolates. Emerging Infectious Diseases.2001,7 (1):24-34
[21]张心如,罗宜熟,杜干英等.动物源性耐药菌与人类安全.兽药与饲料添加剂.2004,9(3)：3-6
[22]C. Fitzgerald, I. Nachamkin, P. Murray, et al. Campylobacter and Arcobacter. Manual of clinical microbiology:Volume 1.2006 (Ed.9):933-946
[23]Y. Saenz, M. Zarazaga, M. Lantero, et al. Antibiotic Resistance in Campylobacter strains Isolated from Animals, Foods, and Humans in Spain in 1997-1998. Antimicrobial Agents and Chemotherapy.2000,44 (2):267-271
[24]A.O. Coker, R.D. Isokpehi, B.N. Thomas, et al. Human Campylobacteriosis in Developing Countries. Emerging Infectious Diseases.2002,8 (3):237-244
[25]M. Shahid, M. Amjad, S.U. Kazmi. Breast Feeding May Protect Children against Campylobacter Jejuni Associated Diarrhoea. Journal of the College of Physicians and Surgeons Pakistan.1996,6 (1):43-46
[26]M. Alam, Y.N. Akhtar, S.S. Ali, et al. Seasonal Variation in Bacterial Pathogens Isolated from Stool Samples in Karachi, Pakistan. Journal of Pakistan Medical Association.2003,53 (3):125-129
[27]J. Bardon, M. Kolaf, R. Karpiskova, et al. Prevalence of Thermotolerant Campylobacter Spp. In Broilers at Retail in the Czech Republic and Their Antibiotic Resistance. Food Control.2011,22 (2): 328-332
[28]M.J. Blaser, J. Engberg, I. Nachamkin, et al. Clinical Aspects of Campylobacter Jejuni and Campylobacter Coli Infections. ASM Press,2008
[29]A. Lastovica, M. Skirrow. Clinical significance of Campylobacter and related species other than C. jejuni and C. Coli. Campylobacter.2000,2:89-120
[30]D.J. Wilson, E. Gabriel, A.J. Leatherbarrow, et al. Tracing the Source of Campylobacteriosis. PLOS Genetics.2008,4 (9):e1000203
[31]J. Silva, D. Leite, M. Fernandes, et al. Campylobacter Spp. As a Foodborne Pathogen:A Review. Frontiers in microbiology.2011,2
[32]B.M. Allos, M.J. Blaser. Campylobacter Jejuni and the Expanding Spectrum of Related Infections. Clinical Infectious Diseases.1995,20 (5):1092-1099
[33]N. McCarthy, J. Giesecke. Incidence of Guillain-Barre Syndrome Following Infection with Campylobacter Jejuni. American Journal of Epidemiology.2001,153 (6):610-614
[34]H. Jiang, M.-J. Zhang, R.-C. Liu, et al. Characteristics of Lipo-Oligosaccharide Loci of Campylobacter Jejuni Isolates Associated with Guillain-Barre Syndrome from Hebei, China. International Journal of Molecular Sciences.2010,11 (3):1155-1161
[35]M. Zhang, Q. Li, L. He, et al. Association Study between an Outbreak of Guillain-Barre Syndrome in Jilin, China, and Preceding Campylobacter Jejuni Infection. Foodborne Pathogens and Disease.2010,7 (8):913-919
[36]J.L. Huang, H.Y. Xu, G.Y. Bao, et al. Epidemiological Surveillance of Campylobacter Jejuni in Chicken, Dairy Cattle and Diarrhoea Patients. Emerging Infectious Diseases.2009,137 (8): 1111-1120
[37]D.J. Kelly. The Physiology and Metabolism of Campylobacter Jejuni and Helicobacter Pylori. Symposium series (Society for Applied Microbiology).2001 (30):16S-24S
[38]N.J. Stern, M.R. Clavero, J.S. Bailey, et al. Campylobacter Spp. In Broilers on the Farm and after Transport. Poultry Science.1995,74 (6):937-941
[39]N. Diane G. The Ecology of Campylobacter Jejuni in Avian and Human Hosts and in the Environment. International Journal of Infectious Diseases.2002,6, Supplement 3 (0):S16-S21
[40]L. Moran, P. Scates, R.H. Madden. Prevalence of Campylobacter Spp. In Raw Retail Poultry on Sale in Northern Ireland. Journal of Food Protection.2009,72 (9):1830-1835
[41]N.J. Stern, J.E. Line. Comparison of 3 Methods for Recovery of Campylobacter Spp from Broiler Carcasses. Journal of Food Protection.1992,55 (9):663-666
[42]A.W. van de Giessen, B.P. Bloemberg, W.S. Ritmeester, et al. Epidemiological Study on Risk Factors and Risk Reducing Measures for Campylobacter Infections in Dutch Broiler Flocks. Epidemiology and Infection.1996,117 (2):245-250
[43]R.H. Mdegela, H.E. Nonga, H.A. Ngowi, et al. Prevalence of Thermophilic Campylobacter Infections in Humans, Chickens and Crows in Morogoro, Tanzania. Journal of Veterinary Medicine Series B-infectious Diseases and Veterinary Public Health.2006,53 (3):116-121
[44]J. Anderson, B.J. Horn, B.J. Gilpin. The Prevalence and Genetic Diversity of Campylobacter Spp. In Domestic 'Backyard' Poultry in Canterbury, New Zealand. Zoonoses Public Health.2011
[45]X. Chen, G.W. Naren, C.M. Wu, et al. Prevalence and Antimicrobial Resistance of Campylobacter Isolates in Broilers from China. Veterinary Microbiology.2010,144 (1-2):133-139
[46]R. Takahashi, F. Shahada, T. Chuma, et al. Analysis of Campylobacter Spp. Contamination in Broilers from the Farm to the Final Meat Cuts by Using Restriction Fragment Length Polymorphism of the Polymerase Chain Reaction Products. International Journal of Food Microbiology.2006,110 (3): 240-245
[47]Y. Ghafir, B. China, K. Dierick, et al. A Seven-Year Survey of Campylobacter Contamination in Meat at Different Production Stages in Belgium. International Journal of Food Microbiology.2007, 116(1):111-120
[48]J.E.L. Corry, H.I. Atabay. Poultry as a Source of Campylobacter and Related Organisms. Journal of Applied Microbiology.2001,90:96s-114s
[49]J.E. Corry, H.I. Atabay. Poultry as a Source of Campylobacter and Related Organisms. Symposium series (Society for Applied Microbiology).2001 (30):96S-114S
[50]O.M. Cloak, G. Duffy, J.J. Sheridan, et al. A Survey on the Incidence of Campylobacter Spp. And the Development of a Surface Adhesion Polymerase Chain Reaction (Sa-Pcr) Assay for the Detection of Campylobacter Jejuni in Retail Meat Products. Food Microbiology.2001,18 (3):287-298
[51]T. Humphrey, S. O'Brien, M. Madsen. Campylobacters as Zoonotic Pathogens:A Food Production Perspective. International Journal of Food Microbiology.2007,117 (3):237-257
[52]V. Atanassova, C. Ring. Prevalence of Campylobacter Spp. In Poultry and Poultry Meat in Germany. International Journal of Food Microbiology.1999,51 (2-3):187-190
[53]N.J. Stern, M.C. Robach. Enumeration of Campylobacter Spp. In Broiler Feces and in Corresponding Processed Carcasses. Journal of Food Protection.2003,66 (9):1557-1563
[54]Q.H. Luu, T.H. Tran, D.C. Phung, et al. Study on the Prevalence of Campylobacter Spp. From Chicken Meat in Hanoi, Vietnam. Annals of the New York Academy of Sciences.2006,1081:273-275
[55]R.J. Meldrum, I.G. Wilson. Salmonella and Campylobacter in United Kingdom Retail Raw Chicken in 2005. Journal of Food Protection.2007,70 (8):1937-1939
[56]S. Cui, B. Ge, J. Zheng, et al. Prevalence and Antimicrobial Resistance of Campylobacter Spp. And Salmonella Serovars in Organic Chickens from Maryland Retail Stores. Applied and Environmental Microbiology.2005,71 (7):4108-4111
[57]F. Han, S.I. Lestari, S. Pu, et al. Prevalence and Antimicrobial Resistance among Campylobacter Spp. In Louisiana Retail Chickens after the Enrofloxacin Ban. Foodborne Pathogens and Disease.2009,6 (2):163-171
[58]H. Suzuki, S. Yamamoto. Campylobacter Contamination in Retail Poultry Meats and by-Products in the World:A Literature Survey. Journal of Veterinary Medical Science.2009,71 (3): 255-261
[59]T.L. Wong, L. Hollis, A. Cornelius, et al. Prevalence, Numbers, and Subtypes of Campylobacter Jejuni and Campylobacter Coli in Uncooked Retail Meat Samples. Journal of Food Protection.2007,70 (3):566-573
[60]P. Mullner, J.M. Collins-Emerson, A.C. Midwinter, et al. Molecular Epidemiology of Campylobacter Jejuni in a Geographically Isolated Country with a Uniquely Structured Poultry Industry. Applied and Environmental Microbiology.2010,76 (7):2145-2154
[61]C. Yang, Y. Jiang, K. Huang, et al. Application of Real-Time Pcr for Quantitative Detection of Campylobacter Jejuni in Poultry, Milk and Environmental Water. FEMS Immunology and Medical Microbiology.2003,38 (3):265-271
[62]袁标,吴开富,刘德超等.应用PCR技术快速检测禽肉中弯曲菌.肉类工业.2010(04)：43-45
[63]焦扬,翟伟华,黄金林.鸡肉屠宰加工环节弯曲菌流行病学调查与分析.肉类工业.2011(04)：44-46
[64]N. Luo, S. Pereira, O. Sahin, et al. Enhanced in Vivo Fitness of Fluoroquinolone-Resistant Campylobacter Jejuni in the Absence of Antibiotic Selection Pressure. Proceedings of the National Academy of Sciences of the United States of America.2005,102 (3):541-546
[65]L.J. Piddock, V. Ricci, L. Pumbwe, et al. Fluoroquinolone Resistance in Campylobacter Species from Man and Animals:Detection of Mutations in Topoisomerase Genes. Journal of Antimicrobial Chemotherapy.2003,51 (1):19-26
[66]M. Yan, O. Sahin, J. Lin, et al. Role of the CmeABC Efflux Pump in the Emergence of Fluoroquinolone-Resistant Campylobacter under Selection Pressure. Journal of Antimicrobial Chemotherapy.2006,58 (6):1154-1159
[67]D. Acheson, B.M. Allos. Campylobacter Jejuni Infections:Update on Emerging Issues and Trends. Clinical Infectious Diseases.2001,32 (8):1201-1206
[68]M. Lehtopolku. Antimicrobial Resistance in Campylobacter Jejuni and Campylobacter Coli. 2011,http://www.doria.fi/bitstream/handle/10024/70812/AnnalesD976Lehtopolku.pdf?sequence=1
[69]S.S. Qin, C.M. Wu, Y. Wang, et al. Antimicrobial Resistance in Campylobacter Coli Isolated from Pigs in Two Provinces of China. International Journal of Food Microbiology.2011,146 (1):94-98
[70]许海燕,黄金林,包广宇等.扬州市区腹泻人群空肠弯曲菌和结肠弯曲菌流行状况及耐药性分析.中国人兽共患病学报.2008(1)：58-62
[71]张茂俊,张建中.空肠弯曲菌耐药现状.疾病监测.2007(12)：793-796+811
[72]M. Zhang, Y. Gu, L. He, et al. Molecular Typing and Antimicrobial Susceptibility Profiles of Campylobacter Jejuni Isolates from North China. Journal of Medical Microbiology.2010,59 (Pt 10): 1171-1177
[73]A. Gibreel, D.E. Taylor. Macrolide Resistance in Campylobacter Jejuni and Campylobacter Coli. Journal of Antimicrobial Chemotherapy.2006,58 (2):243-255
[74]D.B. Caldwell, Y. Wang, J. Lin. Development, Stability, and Molecular Mechanisms of Macrolide Resistance in Campylobacter Jejuni. Antimicrobial Agents and Chemotherapy.2008,52 (11): 3947-3954
[75]S. Qin, Y. Wang, Q. Zhang, et al. Report of Ribosomal RNA Methylase Gene erm (B) in Multidrug-Resistant Campylobacter Coli. Journal of Antimicrobial Chemotherapy.2013:492
[76]J. Lin, L.O. Michel, Q. Zhang. CmeABC Functions as a Multidrug Efflux System in Campylobacter Jejuni. Antimicrobial Agents and Chemotherapy.2002,46 (7):2124-2131
[77]S. Zhao, S.R. Young, E. Tong, et al. Antimicrobial Resistance of Campylobacter Isolates from Retail Meat in the United States between 2002 and 2007. Applied and Environmental Microbiology. 2010,76 (24):7949-7956
[78]A. Gibreel, D.M. Tracz, L. Nonaka, et al. Incidence of Antibiotic Resistance in Campylobacter Jejuni Isolated in Alberta, Canada, from 1999 to 2002, with Special Reference to Tet(O)-Mediated Tetracycline Resistance. Antimicrobial Agents and Chemotherapy.2004,48 (9): 3442-3450
[79]A. Gibreel, N.M. Wetsch, D.E. Taylor. Contribution of the CmeABC Efflux Pump to Macrolide and Tetracycline Resistance in Campylobacter Jejuni. Antimicrobial Agents and Chemotherapy.2007,51 (9):3212-3216
[80]J. Ruiz, F. Marco, I. Oliveira, et al. Trends in Antimicrobial Resistance in Campylobacter Spp. Causing Traveler's Diarrhea. Agricultural Production and Market Information System.2007,115 (3): 218-224
[81]M.M. Feizabadi, S. Dolatabadi, M.R. Zali. Isolation and Drug-resistant Patterns of Campylobacter Strains Cultured from Diarrheic Children in Tehran. Japanese journal of infectious diseases.2007,60 (4):217-219
[82]L. Scott, P. Menzies, R.J. Reid-Smith, et al. Antimicrobial Resistance in Campylobacter Spp. Isolated from Ontario Sheep Flocks and Associations between Antimicrobial Use and Antimicrobial Resistance. Zoonoses Public Health.2012,59 (4):294-301
[83]卢玲,郁庆福.不同来源的空肠弯曲菌对20种抗生素敏感性调查.中国人兽共患病杂志.1990(3)：45-46
[84]侯凤琴,沈宝铨,孙新婷.200株弯曲菌对抗生素敏感性研究.中华医院感染学杂志.2001,11(6)：406-408
[85]Q. Zhang, P.J. Plummer, I. Nachamkin, et al. Mechanisms of Antibiotic Resistance in Campylobacter. Campylobacter.2008 (3):263-276
[86]X.-Z. Li, M. Mehrotra, S. Ghimire, et al. P-Lactam Resistance and P-Lactamases in Bacteria of Animal Origin. Veterinary microbiology.2007,121 (3):197-214
[87]J. Wagner, M. Jabbusch, M. Eisenblatter, et al. Susceptibilities of Campylobacter Jejuni Isolates from Germany to Ciprofloxacin, Moxifloxacin, Erythromycin, Clindamycin, and Tetracycline. Antimicrobial Agents and Chemotherapy.2003,47 (7):2358-2361
[88]M. Cannon, S. Harford, J. Davies. A Comparative Study on the Inhibitory Actions of Chloramphenicol, Thiamphenicol and Some Fluorinated Derivatives. Journal of Antimicrobial Chemotherapy.1990,26 (3):307-317
[89]CAC. Principles and Guidelines for the Conduct of Microbiological Risk Assessment. CAC/GL.1999,30:1-6
[90]D. Vose, J. Acar, F. Anthony, et al. Antimicrobial Resistance:Risk Analysis Methodology for the Potential Impact on Public Health of Antimicrobial Resistant Bacteria of Animal Origin. International Office of Epizootics.2001,20 (3):811-827
[91]E. Snary, S. McEwen, L. Guardabassi, et al. Antimicrobial Resistance Risk Assessment. Guide to Antimicrobial Use in Animals.2008:27
[92]S. Forsythe. The Microbiological Risk Assessment of Food. Wiley Online Library,2007
[93]WHO. Hazard Characterization for Pathogens in Food and Water:Guidelines. Food and Agriculture Organization of the United Nations,2003
[94]A.M. Lammerding, A. Fazil. Hazard Identification and Exposure Assessment for Microbial Food Safety Risk Assessment. International Journal of Food Microbiology.2000,58 (3):147-157
[95]CAC. Proposed Draft Guidelines for Risk Analysis of Foodborne Antimicrobial Resistance. Jeju, Republic of Korea,12-16 October 2009
[96]D. Vose. Risk Analysis:A Quantitative Guide. John Wiley & Sons,2008
[97]D. Burch. Risk Assessment-Campylobacter Infection Transmission from Pigs to Man Using Erythromycin Resistance as a Marker. Pig Journal.2002,50:53-58
[98]F. Moutou, B. Dufour, Y. Ivanov. A Qualitative Assessment of the Risk of Introducing Foot and Mouth Disease into Russia and Europe from Georgia, Armenia and Azerbaijan. International Office of Epizootics.2001,20 (3):723-730
[99]FDA. Guidance for Industry 152:Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern. Rockville, Md, 2003
[100]M. Coleman, H. Marks. Qualitative and Quantitative Risk Assessment. Food Control.1999, 10 (4):289-297
[101]H.S. Hurd, S. Doores, D. Hayes, et al. Public Health Consequences of Macrolide Use in Food Animals:A Deterministic Risk Assessment. Journal of Food Protection.2004,67 (5):980-992
[102]F.O. Hoffman, S. Kaplan. Beyond the Domain of Direct Observation:How to Specify a Probability Distribution That Represents the "State of Knowledge" About Uncertain Inputs. Risk Analysis.1999,19(1):131-134
[103]A.C. Davison. Bootstrap Methods and Their Application. Cambridge university press,1997
[104]A. Gelman, J.B. Carlin, H.S. Stern, et al. Bayesian Data Analysis. CRC press,2013
[105]D.F. Groebner, P.W. Shannon, P.C. Fry, et al. Business Statistics:A Decision Making Approach. Prentice Hall/Pearson,2011
[106]E.L. Snary, L.A. Kelly, H.C. Davison, et al. Antimicrobial Resistance:A Microbial Risk Assessment Perspective. Journal of Antimicrobial Chemotherapy.2004,53 (6):906-917
[107]L. Alban, E.O. Nielsen, J. Dahl. A Human Health Risk Assessment for Macrolide-Resistant Campylobacter Associated with the Use of Macrolides in Danish Pig Production. Preventive Veterinary Medicine.2008,83 (2):115-129
[108]L.A. Cox, Jr., D.A. Popken. Assessing Potential Human Health Hazards and Benefits from Subtherapeutic Antibiotics in the United States:Tetracyclines as a Case Study. Risk Analysis.2010,30 (3):432-457
[109]S.A. Anderson, R.W. Yeaton Woo, L.M. Crawford. Risk Assessment of the Impact on Human Health of Resistant Campylobacter Jejuni from Fluoroquinolone Use in Beef Cattle. Food Control.2001,12(1):13-25
[110]H.S. Hurd, C. Enoe, L. Sorensen, et al. A Stochastic Assessment of the Public Health Risks of the Use of Macrolide Antibiotics in Food Animals. Risk Analysis.2008,28 (3):695-710
[111]L.A.T. Cox, D.A. Popken. Quantifying Potential Human Health Impacts of Animal Antibiotic Use:Enrofloxacin and Macrolides in Chickens. Risk Analysis.2006,26 (1):135-146
[112]FDA-CVM. The Human Health Impact of Fluoroquinolone Resistant Campylobacter Attributed to the Consumption of Chicken.2000, http://www.fda.gov/downloads/AnimalVeterinary/SafetyHealth/RecallsWithdrawals/UCM152308.pdf
[113]B. Melero, P. Juntunen, M.L. Hanninen, et al. Tracing Campylobacter Jejuni Strains Along the Poultry Meat Production Chain from Farm to Retail by Pulsed-Field Gel Electrophoresis, and the Antimicrobial Resistance of Isolates. Food Microbiology.2012,32 (1):124-128
[114]D. Linton, A.J. Lawson, R.J. Owen, et al. Pcr Detection, Identification to Species Level, and Fingerprinting of Campylobacter Jejuni and Campylobacter Coli Direct from Diarrheic Samples. Journal of Clinical Microbiology.1997,35 (10):2568-2572
[115]G. Keramas, D.D. Bang, M. Lund, et al. Development of a Sensitive DNA Microarray Suitable for Rapid Detection of Campylobacter Spp. Molecular and Cellular Probes.2003,17 (4): 187-196
[116]CLSI. Institute. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Informational Supplement. Clinical and Laboratory Standards Institute, Wayne,PA.2008, CLSI Document M31-A3
[117]S. Park. The Physiology of Campylobacter Species and Its Relevance to Their Role as Foodborne Pathogens. International Journal of Food Microbiology.2002,74 (3):177
[118]T.M. Osaili, A.R. Alaboudi, R.R. Al-Akhras. Prevalence and Antimicrobial Susceptibility of Campylobacter Spp. In Live and Dressed Chicken in Jordan. Foodborne Pathogens and Disease.2011
[119]王娟,黄秀梅,刘书科等.不同动物源大肠杆菌的耐药性监测分析.中国兽医杂志.2013,49(11)：64-67
[120]M. Skirrow. Campylobacter Enteritis:A" New" Disease. British Medical Journal.1977,2 (6078):9
[121]F. Bolton, D. Coates, D. Hutchinson. The Ability of Campylobacter Media Supplements to Neutralize Photochemically Induced Toxicity and Hydrogen Peroxide. Journal of Applied Microbiology. 1984,56(1):151-157
[122]J.E. Corry, D. Post, P. Colin, et al. Culture Media for the Isolation of Campylobacters. Progress in Industrial Microbiology.1995,34:129-162
[123]F. Bolton, D. Coates, P. Hinchliffe, et al. Comparison of Selective Media for Isolation of Campylobacter Jejuni/Coli. Journal of Clinical Pathology.1983,36 (1):78-83
[124]C. Baylis, S. MacPhee, K. Martin, et al. Comparison of Three Enrichment Media for the Isolation of Campylobacter Spp. From Foods. Journal of Applied Microbiology.2000,89 (5):884-891
[125]B.G. Meerburg, A. Kijlstra. Role of Rodents in Transmission of Salmonella and Campylobacter. Journal of the Science of Food and Agriculture.2007,87 (15):2774-2781
[126]M. Hofshagen, H. Kruse. Reduction in Flock Prevalence of Campylobacter Spp. In Broilers in Norway after Implementation of an Action Plan. Journal of Food Protection.2005,68 (10): 2220-2223
[127]H. Hariharan, S. Sharma, A. Chikweto, et al. Antimicrobial Drug Resistance as Determined by the E-Test in Campylobacter Jejuni, C. Coli, and C. Lari Isolates from the Ceca of Broiler and Layer Chickens in Grenada. Comparative Immunology, Microbiology and Infectious Diseases.2009,32 (1): 21-28
[128]I. Henry, J. Reichardt, M. Denis, et al. Prevalence and Risk Factors for Campylobacter Spp. In Chicken Broiler Flocks in Reunion Island (Indian Ocean). Preventive Veterinary Medicine.2011, 100 (1):64-70
[129]I. Damjanova, M. Jakab, T. Farkas, et al. From Farm to Fork Follow-up of Thermotolerant Campylobacters Throughout the Broiler Production Chain and in Human Cases in a Hungarian County During a Ten-Months Period. International Journal of Food Microbiology.2011,150 (2):95-102
[130]D. Ewnetu, A. Mihret. Prevalence and Antimicrobial Resistance of Campylobacter Isolates from Humans and Chickens in Bahir Dar, Ethiopia. Foodborne Pathogens and Disease.2010,7 (6): 667-670
[131]F. Han, S.I. Lestari, S. Pu, et al. Prevalence and Antimicrobial Resistance among Campylobacter Spp. In Louisiana Retail Chickens after the Enrofloxacin Ban. Foodborne Pathogens and Disease.2009,6 (2):163-171
[132]Y.-S. Kang, Y.-S. Cho, S.-K. Yoon, et al. Prevalence and Antimicrobial Resistance of Campylobacter Jejuni and Campylobacter Coli Isolated from Raw Chicken Meat and Human Stools in Korea. Journal of Food Protection.2006,69 (12):2915-2923
[133]M. Norstrom, G. Johnsen, M. Hofshagen, et al. Antimicrobial Resistance in Campylobacter Jejuni from Broilers and Broiler House Environments in Norway. Journal of Food Protection.2007,70 (3):736-738
[134]唐雪莲,佟恒敏.喹诺酮类药物研究进展及在兽医临床的应用问题.黑龙江畜牧兽医.2001(03)：24-26
[135]L.B. Price, E. Johnson, R. Vailes, et al. Fluoroquinolone-Resistant Campylobacter Isolates from Conventional and Antibiotic-Free Chicken Products. Environmental Health Perspectives.2005, 113 (5):557-560
[136]M.J. Albert, E. Udo, B.T. Jose, et al. Tetracycline Resistance Is Frequent among Campylobacter Jejuni Isolates from Kuwait. Microbial Drug Resistance.2009,15 (2):115-120
[137]P. Juntunen, T. Laurila, M. Heinonen, et al. Absence of Tetracycline Resistance in Campylobacter Coli Isolates from Finnish Finishing Pigs Treated with Chlortetracycline. Journal of Applied Microbiology.2013,114 (4):974-981
[138]J.I. Dasti, U. Groβ, S. Pohl, et al. Role of the Plasmid-Encoded Tet (O) Gene in Tetracycline-Resistant Clinical Isolates of Campylobacter Jejuni and Campylobacter Coli. Journal of Medical Microbiology.2007,56 (6):833-837
[139]A. Noormohamed, M.K. Fakhr. Incidence and Antimicrobial Resistance Profiling of Campylobacter in Retail Chicken Livers and Gizzards. Foodbome Pathogens and Disease.2012,9 (7): 617-624
[140]A. Thibodeau, P. Fravalo, S. Laurent-Lewandowski, et al. Presence and Characterization of Campylobacter Jejuni in Organically Raised Chickens in Quebec. Canadian Journal of Veterinary Research.2011,75 (4):298-307
[141]B.M. Allos, M.J. Blaser. Campylobacter Jejuni and the Expanding Spectrum of Related Infections. Clinical Infectious Diseases.1995,20 (5):1092-1099; 1100-1091
[142]A.S. Obeng, H. Rickard, M. Sexton, et al. Antimicrobial Susceptibilities and Resistance Genes in Campylobacter Strains Isolated from Poultry and Pigs in Australia. Journal of Applied Microbiology.2012,113 (2):294-307
[143]E. Shin, Y. Oh, M. Kim, et al. Antimicrobial Resistance Patterns and Corresponding Multilocus Sequence Types of the Campylobacter Jejuni Isolates from Human Diarrheal Samples. Microbial Drug Resistance.2012
[144]W. Mattheus, N. Botteldoorn, K. Heylen, et al. Trend Analysis of Antimicrobial Resistance in Campylobacter Jejuni and Campylobacter Coli Isolated from Belgian Pork and Poultry Meat Products Using Surveillance Data of 2004-2009. Foodborne Pathogens and Disease.2012,9 (5): 465-472
[145]D.E. Taylor, D.M. Tracz. Mechanisms of Antimicrobial Resistance in Campylobacter. Campylobacter Molecular and Cell Biology.2005:193-204
[146]王加才,万荣峰,江善祥.超微粉碎对氟苯尼考在肉鸡体内药动学的影响.中国兽药杂志.2008,42(2)：32-35
[147]L. Ma, Z. Shen, G. Naren, et al. Identification of a Novel G2073a Mutation in 23s Rrna in Amphenicol-Selected Mutants of Campylobacter Jejuni. PLoS One.2014,9 (4):e94503
[148]A. Noormohamed, M.K. Fakhr. A Higher Prevalence Rate of Campylobacter in Retail Beef Livers Compared to Other Beef and Pork Meat Cuts. International Journal of Environmental Research and Public Health.2013,10 (5):2058-2068
[149]A. Deckert, A. Valdivieso-Garcia, R. Reid-Smith, et al. Prevalence and Antimicrobial Resistance in Campylobacter Spp. Isolated from Retail Chicken in Two Health Units in Ontario. Journal of Food Protection.2010,73 (7):1317-1324
[150]Y.S. Kang, Y.S. Cho, S.K. Yoon, et al. Prevalence and Antimicrobial Resistance of Campylobacter Jejuni and Campylobacter Coli Isolated from Raw Chicken Meat and Human Stools in Korea. Journal of Food Protection.2006,69 (12):2915-2923
[151]N.P. Varela, R. Friendship, C. Dewey. Prevalence of Resistance to 11 Antimicrobials among Campylobacter Coill Isolated from Pigs on 80 Grower-Finisher Farms in Ontario. Canadian Journal of Veterinary Research.2007,71 (3):189-194
[152]L.-P. Potturi-Venkata, S. Backert, S.L. Vieira, et al. Evaluation of Logistic Processing to Reduce Cross-Contamination of Commercial Broiler Carcasses with Campylobacter Spp. Journal of Food Protection.2007,70 (11):2549-2554
[153]K.T. Elvers, V.K. Morris, D.G. Newell, et al. Molecular Tracking, through Processing, of Campylobacter Strains Colonizing Broiler Flocks. Applied and Environmental Microbiology.2011,77 (16):5722-5729
[154]G. Johnsen, H. Kruse, M. Hofshagen. Genotyping of Thermotolerant Campylobacter from Poultry Slaughterhouse by Amplified Fragment Length Polymorphism. Journal of Applied Microbiology.2007,103 (2):271-279
[155]P. Luber, E. Bartelt. Enumeration of Campylobacter Spp. On the Surface and within Chicken Breast Fillets. Journal of Applied Microbiology.2007,102 (2):313-318
[156]李继昌,鲁成武,符春燕等.氟喹诺酮类药物在禽病防治上的应用.黑龙江畜牧兽医.1998,10：27
[157]H.S. Hurd, S. Doores, D. Hayes, et al. Public Health Consequences of Macrolide Use in Food Animals:A Deterministic Risk Assessment. Journal of Food Protection.2004,67 (5):980-992
[158]许紫建.猪、鸡弯曲菌的分离鉴定和耐药性分析及空肠弯曲菌Lamp检测方法的研究[硕士]：河北农业大学.2013
[159]Ministry of Agriculture, Forestry and Fisheries. A Report on the Japanese Veterinary Antimicrobial Resistance Monitoring System 2000 to 2007.2009, http://www.maff.go.jp/nval/english/pdf/jvarm2000_2007_final_201005.pdf
[160]A.A. Delsol, J. Sunderland, M.J. Woodward, et al. Emergence of Fluoroquinolone Resistance in the Native Campylobacter Coli Population of Pigs Exposed to Enrofloxacin. Journal of Antimicrobial Chemotherapy.2004,53 (5):872-874
[161]F.M. Aarestrup, E.M. Nielsen, M. Madsen, et al. Antimicrobial Susceptibility Patterns of Thermophilic Campylobacter Spp. From Humans, Pigs, Cattle, and Broilers in Denmark. Antimicrobial Agents and Chemotherapy.1997,41(10):2244-2250
[162]司徒潮满,赖植发,张勇等.深圳市售活禽空肠弯曲菌带菌及禽肉污染状况调查.华南预防医学.2011,37(2)：48-48
[163]J. Boes, L. Nersting, E.M. Nielsen, et al. Prevalence and Diversity of Campylobacter Jejuni in Pig Herds on Farms with and without Cattle or Poultry. Journal of Food Protection.2005,68 (4): 722-727
[164]D. Taylor, L. Ng, H. Lior. Susceptibility of Campylobacter Species to Nalidixic Acid, Enoxacin, and Other DNA Gyrase Inhibitors. Antimicrobial Agents and Chemotherapy.1985,28 (5): 708-710
[165]T.D. Gootz, B.A. Martin. Characterization of High-Level Quinolone Resistance in Campylobacter Jejuni. Antimicrobial Agents and Chemotherapy.1991,35 (5):840-845
[166]P.F. McDermott, S.M. Bodeis, L.L. English, et al. Ciprofloxacin Resistance in Campylobacter Jejuni Evolves Rapidly in Chickens Treated with Fluoroquinolones. Journal of Infectious Diseases.2002,185 (6):837-840
[167]N. Luo, O. Sahin, J. Lin, et al. In Vivo Selection of Campylobacter Isolates with High Levels of Fluoroquinolone Resistance Associated with Gyra Mutations and the Function of the Cmeabc Efflux Pump. Antimicrobial Agents and Chemotherapy.2003,47 (1):390-394
[168]M. van Boven, K.T. Veldman, M.C. de Jong, et al. Rapid Selection of Quinolone Resistance in Campylobacter Jejuni but Not in Escherichia Coli in Individually Housed Broilers. Journal of Antimicrobial Chemotherapy.2003,52 (4):719-723
[169]尹彦勋,罗平涛.中国肉鸡产业的发展现状及趋势.全球肉鸡产业论坛暨第二届中国白羽肉鸡产业发展大会会刊.2010
[170]辛翔飞,刘春芳,王济民.我国肉鸡产业发展现状、问题与对策.中国家禽.2011(04)：6-9
[171]王济民,申秋红,张瑞荣.中国肉鸡产业发展趋势.今日畜牧兽医.2010(06)：1-3
[172]高俊岭,李玫.1994-2014年全球鸡肉供需和产量回顾与预测.饲料广角.2005(17)：40-42
[173]王振国,罗雁菲,肖成蕊等.鸡肉中弯曲杆菌属的分离与鉴定.中国畜产与食品.2005,7(2)：53-54
[174]M.S. Dryden, R.J. Gabb, S.K. Wright. Empirical Treatment of Severe Acute Community-Acquired Gastroenteritis with Ciprofloxacin. Clinical Infectious Diseases.1996,22 (6): 1019-1025
[175]M. Sessmentseries. Risk Assessment of Campylobacter Spp. In Broiler Chickens.2009
[176]王君,刘秀梅,郭云昌.鸡肉空肠弯曲菌标准制定过程中风险评估的应用.卫生研究.2010(05)：563-566
[177]沈和萍,吴蔚.小儿空肠弯曲菌肠炎534例分析.中国儿童保健杂志.2007,14(6)：640-641
[178]J.W. Sanders, D.W. Isenbarger, S.E. Walz, et al. An Observational Clinic-Based Study of Diarrheal Illness in Deployed United States Military Personnel in Thailand:Presentation and Outcome of Campylobacter Infection. American Journal of Tropical Medicine and Hygiene.2002,67 (5): 533-538
[179]H.L. DuPont. Use of Quinolones in the Treatment of Gastrointestinal Infections. European Journal of Clinical Microbiology and Infectious Diseases.1991,10 (4):325-329
[180]B.T. Solow, O.M. Cloak, P.M. Fratamico. Effect of Temperature on Viability of Campylobacter Jejuni and Campylobacter Coli on Raw Chicken or Pork Skin. Journal of Food Protection.2003,66 (11):2023-2031
[181]E.K. Jagusztyn-Krynicka, P. Laniewski, A. Wyszynska. Update on Campylobacter Jejuni Vaccine Development for Preventing Human Campylobacteriosis. Expert Review of Vaccines.2009,8 (5):625-645
[182]C.C. Tam, S.J. O'Brien, I. Petersen, et al. Guillain-Barre Syndrome and Preceding Infection with Campylobacter, Influenza and Epstein-Barr Virus in the General Practice Research Database. PLoS One.2007,2 (4):e344
[183]杨国昌.甲氟哌酸的抗菌活性、药理和临床应用.国外医药(抗生素分册).1990(02)：129-135
[184]梁诚.氟喹诺酮类药物生产现状与研究进展.精细与专用化学品.2005(05)：1-4
[185]H.P. Endtz, G.J. Ruijs, B. van Klingeren, et al. Quinolone Resistance in Campylobacter Isolated from Man and Poultry Following the Introduction of Fluoroquinolones in Veterinary Medicine. Journal of Antimicrobial Chemotherapy.1991,27 (2):199-208
[186]P.N. Gaunt, L.J. Piddock. Ciprofloxacin Resistant Campylobacter Spp. In Humans:An Epidemiological and Laboratory Study. Journal of Antimicrobial Chemotherapy.1996,37 (4):747-757
[187]P.N. Gaunt, L.J.V. Piddock. Ciprofloxacin Resistant Campylobacter Spp. In Humans:An Epidemiological and Laboratory Study. Journal of Antimicrobial Chemotherapy.1996,37 (4):747-757
[188]崔生辉,李景云,马越.细菌对氟喹诺酮类药物的耐药机制.中国药房.2007(02)：148-150
[189]H. Yang, S. Chen, D.G. White, et al. Characterization of Multiple-Antimicrobial-Resistant Escherichia Coli Isolates from Diseased Chickens and Swine in China. Journal of Clinical Microbiology.2004,42 (8):3483-3489
[190]S. Cui, B. Ge, J. Zheng, et al. Prevalence and Antimicrobial Resistance of Campylobacter Spp. And Salmonella Serovars in Organic Chickens from Maryland Retail Stores. Applied and Environmental Microbiology.2005,71 (7):4108-4111
[191]S. Bagel, V. Hullen, B. Wiedemann, et al. Impact of Gyra and Parc Mutations on Quinolone Resistance, Doubling Time, and Supercoiling Degree of Escherichia Coli. Antimicrobial Agents and Chemotherapy.1999,43 (4):868-875
[192]Q. Zhang, O. Sahin, P.F. McDermott, et al. Fitness of Antimicrobial-Resistant Campylobacter and Salmonella. Microbes and Infection.2006,8 (7):1972-1978
[193]王明华.Qnr介导细菌对喹诺酮类耐药机制的研究[博士]：复旦大学.2010
[194]L.J. Piddock. Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria. Clinical Microbiology Reviews.2006,19 (2):382-402
[195]J. Bjorkman, D.I. Andersson. The Cost of Antibiotic Resistance from a Bacterial Perspective. Drug Resistance Updates.2000,3 (4):237-245
[196]N.D. Luo, S. Pereira, O. Sahin, et al. Enhanced in Vivo Fitness of Fluoroquinolone-Resistant Campylobacter Jejuni in the Absence of Antibiotic Selection Pressure. Proceedings of the National Academy of Sciences of the United States of America.2005,102 (3):541-546
[197]L.B. Price, E. Johnson, R. Vailes, et al. Fluoroquinolone-Resistant Campylobacter Isolates from Conventional and Antibiotic-Free Chicken Products. Environmental Health Perspectives.2005, 113 (5):557-560
[198]K. Pedersen, A. Wedderkopp. Resistance to Quinolones in Campylobacter Jejuni and Campylobacter Coli from Danish Broilers at Farm Level. Journal of Applied Microbiology.2003,94 (1):111-119
[199]K.E. Smith, J.M. Besser, C.W. Hedberg, et al. Quinolone-Resistant Campylobacter Jejuni Infections in Minnesota,1992-1998. Investigation Team. The New England Journal of Medicine.1999, 340(20):1525-1532
[200]J. Reina, N. Borrell, A. Serra. Emergence of Resistance to Erythromycin and Fluoroquinolones in Thermotolerant Campylobacter Strains Isolated from Feces 1987-1991. European Journal of Clinical Microbiology and Infectious Diseases.1992,11 (12):1163-1166
[201]R. Sanchez, V. Fernandez-Baca, M.D. Diaz, et al. Evolution of Susceptibilities of Campylobacter Spp. To Quinolones and Macrolides. Antimicrobial Agents and Chemotherapy.1994, 38(9):1879-1882
[202]H. Endtz, R.P. Mouton, T. Van Der Reyden, et al. Fluoroquinolone Resistance in Campylobacter Spp Isolated from Human Stools and Poultry Products. The Lancet.1990,335 (8692): 787
[203]乔昕,袁宝君,吴高林.南京市2006年鸡肉产品中空肠弯曲菌污染状况调查.江苏预防医学.2007,18(2)：37-38
[204]徐君怡,曹际娟,郑秋月等.多重Pcr-变性高效液相色谱检测食品中空肠弯曲菌和结肠弯曲菌.中国预防兽医学报.2009,31(3)：207-212
[205]L. Desheng, C. Zhixin, W. Bolun. Age Distribution of Diarrhoeal and Healthy Children Infected with Campylobacter Jejuni. Journal of Tropical Medicine and Hygiene.1992,95 (3):218-220
[206]J. Chen, X.T. Sun, Z. Zeng, et al. Campylobacter Enteritis in Adult Patients with Acute Diarrhea from 2005 to 2009 in Beijing, China. Chinese Medical Journal.2011,124 (10):1508-1512
[207]蒋龙芳,汪芬娟,汪永良等.杭州市萧山区人群腹泻病发病及就诊现况分析.中国自然医学杂志.2010(03)：198-200
[208]金立坚,袁珩,张辉等.四川省腹泻病现状调查.预防医学情报杂志.2009(03)：183-186
[209]梁大斌,林玫,李永红等.广西城乡腹泻病调查病例临床特征分析.中国热带医学.2009(04)：659-660
[210]柴程良.腹泻病流行特征与经济负担研究[硕士]：浙江大学.2010
[211]杨建军.甘肃省腹泻病流行特征和经济负担研究[硕士]：中国疾病预防控制中心.2008
[212]侯凤琴,孙新婷,王贵强.教学医院不合理应用抗菌药物治疗成人急性感染性腹泻调查.中国药学.2010(03)：229-234
[213]李霖,周国民.131例小儿腹泻患者住院治疗回顾性分析.检验医学与临床.2010(02)：106-107+110
[214]徐琴,潘艳萍.2008～2009年淄博市淄川区腹泻病监测分析.预防医学论坛.2011(04)：339-340+343
[215]罗宏丽,肖顺林,王国俊.180例小儿急性腹泻病住院患者抗菌药物应用分析.中国药物应用与监测.2011(05)：306-308
[216]周志衡,王家骥,钟永煜等.粤西地区基层医院小儿腹泻病抗生素使用情况分析.中国热带医学.2006(08)：1511-1512
[217]缪晓辉,张元浩.感染性腹泻的治疗：选择与放弃.中国全科医学：医生读者版.2011,14(6)：30-32
[218]L.V. Piddock. Quinolone Resistance and Campylobacter. Clinical Microbiology and Infection.1999 (5):239-243
[219]C. Pigrau, R. Bartolome, B. Almirante, et al. Bacteremia Due to Campylobacter Species: Clinical Findings and Antimicrobial Susceptibility Patterns. Clinical Infectious Diseases.1997,25 (6): 1414-1420
[220]B.M. Korczak, M. Zurfluh, S. Emler, et al. Multiplex Strategy for Multilocus Sequence Typing, Fla Typing, and Genetic Determination of Antimicrobial Resistance of Campylobacter Jejuni and Campylobacter Coli Isolates Collected in Switzerland. Journal of Clinical Microbiology.2009,47 (7):1996-2007
[221]O. Hue, V. Allain, M.J. Laisney, et al. Campylobacter Contamination of Broiler Caeca and Carcasses at the Slaughterhouse and Correlation with Salmonella Contamination. Food Microbiology. 2011,28 (5):862-868
[222]H. Hilmarsson, H. Thormar, J.H. Thrainsson, et al. Effect of Glycerol Monocaprate (Monocaprin) on Broiler Chickens:An Attempt at Reducing Intestinal Campylobacter Infection. Poultry Science.2006,85 (4):588-592
[223]J. Ellis-Iversen, F. Jorgensen, S. Bull, et al. Risk Factors for Campylobacter Colonisation During Rearing of Broiler Flocks in Great Britain. Preventive Veterinary Medicine.2009,89 (3-4): 178-184
[224]D. Hermans, A. Martel, K. Van Deun, et al. Intestinal Mucus Protects Campylobacter Jejuni in the Ceca of Colonized Broiler Chickens against the Bactericidal Effects of Medium-Chain Fatty Acids. Poultry Science.2010,89 (6):1144-1155
[225]M.M. Cowan. Plant Products as Antimicrobial Agents. Clinical Microbiology Reviews.1999, 12 (4):564-82
[226]D. Hermans, A. Martel, K. van Deun, et al. The Cinnamon-Oil Ingredient Trans-Cinnamaldehyde Fails to Target Campylobacter Jejuni Strain Kc 40 in the Broiler Chicken Cecum Despite Marked in Vitro Activity. Journal of Food Protection.2011,74 (10):1729-1734
[227]J.A. Wagenaar, M.A.P.V. Bergen, M.A. Mueller, et al. Phage Therapy Reduces Campylobacter jejuni Colonization in Broilers. Veterinary Microbiology.2005,109 (3-4):275-283
[228]D. Hermans, K. Van Deun, W. Messens, et al. Campylobacter Control in Poultry by Current Intervention Measures Ineffective:Urgent Need for Intensified Fundamental Research. Veterinary Microbiology.2011,152 (3-4):219-228
[229]M.J. Nauta, F.J. van der Wal, F.F. Putirulan, et al. Evaluation of the "Testing and Scheduling" Strategy for Control of Campylobacter in Broiler Meat in the Netherlands. International Journal of Food Microbiology.2009,134 (3):216-222
[230]L. Herman, M. Heyndrickx, K. Grijspeerdt, et al. Routes for Campylobacter Contamination of Poultry Meat:Epidemiological Study from Hatchery to Slaughterhouse. Epidemiology and Infection. 2003,131(3):1169-1180
[231]M. Uyttendaele, K. Baert, Y. Ghafir, et al. Quantitative Risk Assessment of Campylobacter Spp. In Poultry Based Meat Preparations as One of the Factors to Support the Development of Risk-Based Microbiological Criteria in Belgium. International Journal of Food Microbiology.2006,111 (2):149-163
[232]L.C. Rodrigues, J.M. Cowden, J.G. Wheeler, et al. The Study of Infectious Intestinal Disease in England:Risk Factors for Cases of Infectious Intestinal Disease with Campylobacter Jejuni Infection. Epidemiology and Infection.2001,127 (2):185-193
[233]D.J. Griggs, M.M. Johnson, J.A. Frost, et al. Incidence and Mechanism of Ciprofloxacin Resistance in Campylobacter Spp. Isolated from Commercial Poultry Flocks in the United Kingdom before, During, and after Fluoroquinolone Treatment. Antimicrobial Agents and Chemotherapy.2005, 49 (2):699-707